10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________

FORM 10-Q

_________________________

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended June 30, 2017

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from________ to________ .

Commission File Number: 1-644

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

DELAWARE	13-1815595
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

300 Park Avenue, New York, New York	10022
(Address of principal executive offices)	(Zip Code)

(212) 310-2000

(Registrant’s telephone number, including area code)

NO CHANGES

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒  No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes ☒  No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒	Accelerated filer ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company)	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class	Shares Outstanding	Date
Common stock, $1.00 par value	880,841,977	June 30, 2017

PART I.FINANCIAL INFORMATION

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Income

 (Dollars in Millions Except Per Share Amounts)

(Unaudited)

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Net sales	$	3,826	$	3,845	$	7,588	$	7,607
Cost of sales	1,526		1,541		3,019		3,055
Gross profit	2,300		2,304		4,569		4,552
Selling, general and administrative expenses	1,333		1,320		2,695		2,674
Other (income) expense, net	114		40		136		67
Operating profit	853		944		1,738		1,811
Interest (income) expense, net	24		25		47		53
Income before income taxes	829		919		1,691		1,758
Provision for income taxes	269		281		520		546
Net income including noncontrolling interests	560		638		1,171		1,212
Less: Net income attributable to noncontrolling interests	36		38		77		79
Net income attributable to Colgate-Palmolive Company	$	524	$	600	$	1,094	$	1,133
Earnings per common share, basic	$	0.59	$	0.67	$	1.24	$	1.27
Earnings per common share, diluted	$	0.59	$	0.67	$	1.23	$	1.26
Dividends declared per common share *	$	0.40	$	0.39	$	1.19	$	1.16

* Two dividends were declared in the first quarter of 2017 and 2016.

See Notes to Condensed Consolidated Financial Statements.

2

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Comprehensive Income

 (Dollars in Millions)

(Unaudited)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016
Net income including noncontrolling interests	$	560		$	638		$	1,171		$	1,212
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	98			(43		)	230			83
Retirement plans and other retiree benefit adjustments	12			12			25			23
Gains (losses) on available-for-sale securities	—			—			—			—
Gains (losses) on cash flow hedges	(3		)	7			(13		)	(4		)
Total Other comprehensive income (loss), net of tax	107			(24		)	242			102
Total Comprehensive income including noncontrolling interests	667			614			1,413			1,314
Less: Net income attributable to noncontrolling interests	36			38			77			79
Less: Cumulative translation adjustments attributable to noncontrolling interests	2			(6		)	9			(5		)
Total Comprehensive income attributable to noncontrolling interests	38			32			86			74
Total Comprehensive income attributable to Colgate-Palmolive Company	$	629		$	582		$	1,327		$	1,240

See Notes to Condensed Consolidated Financial Statements.

3

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Balance Sheets

 (Dollars in Millions)

(Unaudited)

	June 30, 2017			December 31, 2016
Assets
Current Assets
Cash and cash equivalents	$	1,241		$	1,315
Receivables (net of allowances of $75 and $73, respectively)	1,526			1,411
Inventories	1,199			1,171
Other current assets	589			441
Total current assets	4,555			4,338
Property, plant and equipment:
Cost	8,261			7,942
Less: Accumulated depreciation	(4,331		)	(4,102		)
	3,930			3,840
Goodwill	2,191			2,107
Other intangible assets, net	1,340			1,313
Deferred income taxes	360			301
Other assets	204			224
Total assets	$	12,580		$	12,123
Liabilities and Shareholders’ Equity
Current Liabilities
Notes and loans payable	$	13		$	13
Current portion of long-term debt	—			—
Accounts payable	1,131			1,124
Accrued income taxes	404			441
Other accruals	2,232			1,727
Total current liabilities	3,780			3,305
Long-term debt	6,506			6,520
Deferred income taxes	195			246
Other liabilities	2,011			2,035
Total liabilities	12,492			12,106
Shareholders’ Equity
Common stock	1,466			1,466
Additional paid-in capital	1,854			1,691
Retained earnings	19,952			19,922
Accumulated other comprehensive income (loss)	(3,947		)	(4,180		)
Unearned compensation	(2		)	(7		)
Treasury stock, at cost	(19,565		)	(19,135		)
Total Colgate-Palmolive Company shareholders’ equity	(242		)	(243		)
Noncontrolling interests	330			260
Total equity	88			17
Total liabilities and equity	$	12,580		$	12,123

See Notes to Condensed Consolidated Financial Statements.

4

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Cash Flows

(Dollars in Millions)

(Unaudited)

	Six Months Ended
	June 30,
	2017			2016
Operating Activities
Net income including noncontrolling interests	$	1,171		$	1,212
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	226			215
Restructuring and termination benefits, net of cash	78			8
Stock-based compensation expense	53			48
Deferred income taxes	(64		)	(41		)
Voluntary benefit plan contributions	(57		)	(50		)
Cash effects of changes in:
Receivables	(64		)	(132		)
Inventories	9			(35		)
Accounts payable and other accruals	(61		)	69
Other non-current assets and liabilities	14			26
Net cash provided by operations	1,305			1,320
Investing Activities
Capital expenditures	(229		)	(248		)
Purchases of marketable securities and investments	(201		)	(183		)
Proceeds from sale of marketable securities and investments	114			87
Other	4			4
Net cash used in investing activities	(312		)	(340		)
Financing Activities
Principal payments on debt	(1,841		)	(4,078		)
Proceeds from issuance of debt	1,761			4,123
Dividends paid	(716		)	(704		)
Purchases of treasury shares	(660		)	(482		)
Proceeds from exercise of stock options	337			274
Net cash used in financing activities	(1,119		)	(867		)
Effect of exchange rate changes on Cash and cash equivalents	52			2
Net increase (decrease) in Cash and cash equivalents	(74		)	115
Cash and cash equivalents at beginning of the period	1,315			970
Cash and cash equivalents at end of the period	$	1,241		$	1,085
Supplemental Cash Flow Information
Income taxes paid	$	639		$	507

See Notes to Condensed Consolidated Financial Statements.

5

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

1. Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. The Company reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.

For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, filed with the Securities and Exchange Commission.

2. Use of Estimates

Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

3. Recent Accounting Pronouncements

On May 10, 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09, “Compensation–Stock Compensation (Topic 718): Scope of Modification Accounting,” clarifying when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance is effective for the Company on a prospective basis beginning on January 1, 2018, with early adoption permitted. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements as it is not the Company’s practice to change either the terms or conditions of share-based payment awards once they are granted.

On March 10, 2017, the FASB issued ASU No. 2017-07, “Compensation–Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,” changing the presentation of the net periodic benefit cost on the Statement of Income and limiting the amount of net periodic benefit cost eligible for capitalization to assets. The new guidance permits only the service cost component of net periodic benefit cost to be eligible for capitalization. The new guidance also requires entities to present the service cost component of net periodic benefit cost together with compensation costs arising from services rendered by employees during the period. Other components of net periodic benefit cost, which include interest, expected return on assets, amortization of prior service costs and actuarial gains and losses, are required to be presented outside of Operating profit. The line item or items used to present the other components of net periodic benefit cost must be disclosed in the Notes to the Consolidated Financial Statements, if not separately described on the Statement of Income. The new presentation requirement is required to be adopted on a “full retrospective” basis, meaning the standard is applied to all of the periods presented in the financial statements, while the limitation on capitalization can only be adopted on a prospective basis. The new guidance is effective for the Company beginning on January 1, 2018, with early adoption permitted. While the Company is currently assessing the impact of the new standard on its Consolidated Financial Statements, based on its historical results, it anticipates that, as a result of the reclassification, full year Operating profit will increase by approximately $100 annually with no impact on Net income attributable to Colgate-Palmolive Company.

On January 26, 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

6

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

On January 5, 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business,” which provides additional guidance on evaluating whether transactions should be accounted for as acquisitions of assets or businesses. The guidance requires an entity to evaluate if substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the new guidance would define this as an asset acquisition; otherwise, the entity then evaluates whether the asset meets the requirement that a business include, at a minimum, an input and substantive process that together significantly contribute to the ability to create outputs. The guidance is effective for the Company on a prospective basis beginning on January 1, 2018, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On October 24, 2016, the FASB issued ASU No. 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity asset transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. As permitted, the Company early-adopted the new standard on a “modified retrospective” basis, meaning the standard is applied only to the most recent period presented in the financial statements, as of January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

On August 26, 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” which clarifies how certain cash receipts and payments are to be presented in the statement of cash flows. The guidance is effective for the Company beginning on January 1, 2018, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On March 30, 2016, the FASB issued ASU No. 2016-09, “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amended accounting for income taxes related to share-based compensation, the related classification in the statement of cash flows and share award forfeiture accounting. The new guidance was effective for the Company beginning on January 1, 2017. As required subsequent to the adoption of this new guidance, the Company recognized excess tax benefits of $8 and $26 (resulting from an increase in the fair value of an award from grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the three and six months ended June 30, 2017, respectively. These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits were recognized in equity. As permitted, the Company elected to classify excess tax benefits as an operating activity in the Statement of Cash Flows instead of as a financing activity on a prospective basis and did not retrospectively adjust prior periods. Also, as permitted by the new standard, the Company elected to account for forfeitures as they occur.

On March 15, 2016, the FASB issued ASU No. 2016-07, “Investments–Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting,” which eliminated the requirement to retroactively adjust an investment that subsequently qualifies for equity method accounting (as a result of an increase in level of ownership interest or degree of influence) as if the equity method of accounting had been applied during all prior periods that the investment was held. The new standard requires that the investor add the cost of acquiring additional ownership interest in the investee to its current basis and prospectively apply the equity method of accounting. For an available-for-sale investment, any unrealized gains or losses should be recognized in earnings at the date the investment qualifies as an equity method investment. The new guidance was effective for the Company beginning on January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

7

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

On February 25, 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which supersedes Topic 840, “Leases.” The new accounting standard requires the recognition of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The new standard also provides additional guidance on the measurement of the right-of-use assets and lease liabilities and will require enhanced disclosures about the Company’s leasing arrangements. Under current accounting standards, substantially all of the Company’s leases are considered operating leases and, as such, are not recognized on the Consolidated Balance Sheet. This new standard is effective for the Company beginning on January 1, 2019, with early adoption permitted. The standard requires a “modified retrospective” adoption, meaning the standard is applied to leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The Company is currently assessing the impact of the new standard on its Consolidated Financial Statements.

On January 5, 2016, the FASB issued ASU No. 2016-01, “Financial Instruments–Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The updated guidance enhances the reporting model for financial instruments which includes amendments to address aspects of recognition, measurement, presentation and disclosure. The amendment to the standard is effective for the Company beginning on January 1, 2018. While the Company is currently assessing the impact of the new standard, it does not expect this new guidance to have a material impact on its Consolidated Financial Statements.

On July 22, 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory,” which simplifies the subsequent measurement of inventories by replacing the lower of cost or market test with a lower of cost and net realizable value test. The guidance applies only to inventories for which cost is determined by methods other than last-in first-out (“LIFO”) and the retail inventory method. The new guidance was effective for the Company beginning on January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

On May 28, 2014, the FASB and the International Accounting Standards Board issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” by the FASB, provides a comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to its customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures. During 2016, the FASB issued several accounting updates (ASU No. 2016-08, 2016-10 and 2016-12) to clarify implementation guidance and correct unintended application of the guidance. The standard allows for either full retrospective adoption or modified retrospective adoption. The Company plans to adopt the new standard on January 1, 2018, on a “modified retrospective” basis. The Company continues to make progress in its assessment and implementation of the new standard and while the completion of this assessment is still ongoing, based on the progress to date, the Company does not expect the new standard will have a material impact on its revenue recognition accounting policy or its Consolidated Financial Statements.

8

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

4. Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a Global Growth and Efficiency Program (as expanded in 2014 and 2015 as described below, the “2012 Restructuring Program”) for sustained growth. The program’s initiatives are expected to help Colgate ensure sustained solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

On October 23, 2014, the Company’s Board of Directors (the “Board”) approved an expansion of the 2012 Restructuring Program to take advantage of additional savings opportunities.

On October 29, 2015, the Board approved the reinvestment of the funds from the sale of the Company’s laundry detergent business in the South Pacific to expand the 2012 Restructuring Program and extend it for one year through December 31, 2017. The Board approved the implementation plan for this expansion on March 10, 2016. Initiatives under the 2012 Restructuring Program continue to fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities.

The Company continually seeks new projects and ways to advance the implementation of existing projects in order to accelerate savings under the program and, given the challenging market conditions and slowing category growth experienced in the first six months of 2017, it has identified additional opportunities and now estimates charges to be at the upper end of its previously disclosed range. Cumulative pretax charges resulting from the 2012 Restructuring Program, once all phases are approved and implemented, are now estimated to be $1,500 to $1,585 ($1,120 to $1,170 aftertax) as compared to the previous estimate of $1,405 to $1,585 ($1,050 to $1,170 aftertax).

The pretax charges resulting from the 2012 Restructuring Program are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (45%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of related implementation charges resulting directly from exit activities (20%) and the implementation of new strategies (25%). Over the course of the 2012 Restructuring Program, it is currently estimated that approximately 75% of the charges will result in cash expenditures. Anticipated pretax charges for 2017 are now expected to approximate $275 to $360 ($210 to $260 aftertax) as compared to the previous estimate of $180 to $360 ($140 to $260 aftertax). It is expected that substantially all charges resulting from the 2012 Restructuring Program will be incurred by December 31, 2017.

It is currently expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe (25%), Latin America (5%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (5%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that, when it has been fully implemented, the 2012 Restructuring Program will contribute a net reduction of approximately 3,300 to 3,800 positions from the Company’s global employee workforce.

For the three and six months ended June 30, 2017 and 2016, restructuring and related implementation charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Cost of sales	$	21	$	12	$	35	$	20
Selling, general and administrative expenses	17		14		38		40
Other (income) expense, net	104		33		115		54
Total 2012 Restructuring Program charges, pretax	$	142	$	59	$	188	$	114
Total 2012 Restructuring Program charges, aftertax	$	115	$	44	$	146	$	82

9

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:

	Three Months Ended				Six Months Ended				Program-to-date
	June 30,				June 30,				Accumulated Charges
	2017		2016		2017		2016
North America	17	%	23	%	22	%	32	%	17	%
Latin America	3	%	6	%	3	%	7	%	4	%
Europe	55	%	6	%	42	%	7	%	24	%
Asia Pacific	3	%	9	%	3	%	6	%	3	%
Africa/Eurasia	2	%	22	%	2	%	15	%	6	%
Hill’s Pet Nutrition	2	%	17	%	4	%	9	%	7	%
Corporate	18	%	17	%	24	%	24	%	39	%

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,416 ($1,053 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of June 30, 2017
Employee-Related Costs	$	573
Incremental Depreciation	86
Asset Impairments	29
Other	728
Total	$	1,416

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the extension of shared business services and streamlining of global functions; the consolidation of facilities; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; and restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan.

10

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following tables summarize the activity for the restructuring and related implementation charges discussed above and the related accruals:

	Three Months Ended June 30, 2017
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at March 31, 2017	$	44		$	—		$	—	$	123		$	167
Charges	100			4			—		38			142
Cash payments	(8		)	—			—		(46		)	(54		)
Charges against assets	(1		)	(4		)	—		—			(5		)
Foreign exchange	3			—			—		1			4
Balance at June 30, 2017	$	138		$	—		$	—	$	116		$	254

	Six Months Ended June 30, 2017
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2016	$	56		$	—		$	—		$	125		$	181
Charges	108			6			2			72			188
Cash payments	(27		)	—			—			(82		)	(109		)
Charges against assets	(2		)	(6		)	(2		)	—			(10		)
Foreign exchange	3			—			—			1			4
Balance at June 30, 2017	$	138		$	—		$	—		$	116		$	254

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements.

Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $1 and $2 for the three and six months ended June 30, 2017, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 9, Retirement Plans and Other Retiree Benefits).

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three and six months ended June 30, 2017 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $37 and $70, respectively, and contract termination costs and charges resulting directly from exit activities of $1 and $2, respectively. These charges were expensed as incurred.

11

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

5.    Inventories

Inventories by major class are as follows:

	June 30, 2017		December 31, 2016
Raw materials and supplies	$	241	$	266
Work-in-process	47		42
Finished goods	911		863
Total Inventories	$	1,199	$	1,171

6.    Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the six months endedJune 30, 2017 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2016	$	1,466	$	1,691		$	(7	)	$	(19,135	)	$	19,922		$	(4,180	)	$	260
Net income												1,094						77
Other comprehensive income (loss), net of tax															233			9
Dividends												(1,053		)				(16		)
Stock-based compensation expense			53
Shares issued for stock options			126						208
Shares issued for restricted stock units			(17		)				17
Treasury stock acquired									(660		)
Other			1			5			5			(11		)
Balance, June 30, 2017	$	1,466	$	1,854		$	(2	)	$	(19,565	)	$	19,952		$	(3,947	)	$	330

Accumulated other comprehensive income (loss) includes cumulative translation losses of $2,991 and $3,212 at June 30, 2017 and December 31, 2016, respectively, and unrecognized retirement plan and other retiree benefits costs of $952 and $977 at June 30, 2017 and December 31, 2016, respectively.

12

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

7.    Earnings Per Share

	Three Months Ended
	June 30, 2017					June 30, 2016
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	524	883.8	$	0.59	$	600	893.9	$	0.67
Stock options and restricted stock units			7.0					7.2
Diluted EPS	$	524	890.8	$	0.59	$	600	901.1	$	0.67

For the three months endedJune 30, 2017 and 2016, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 5,299,933 and 598,857, respectively.

	Six Months Ended
	June 30, 2017					June 30, 2016
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	1,094	884.2	$	1.24	$	1,133	893.8	$	1.27
Stock options and restricted stock units			6.7					6.9
Diluted EPS	$	1,094	890.9	$	1.23	$	1,133	900.7	$	1.26

For the six months endedJune 30, 2017 and 2016, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 9,051,702 and 356,541, respectively.

Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.

13

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

8. Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedJune 30, 2017 and 2016 were as follows:

	2017						2016
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	57		$	96		$	(8	)	$	(37	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	—			—			—			—
Amortization of net actuarial loss, transition and prior service costs (1)	19			12			16			12
Retirement plans and other retiree benefits adjustments	19			12			16			12
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	—			—			—			—
Reclassification of (gains) losses into net earnings on available-for-sale securities	—			—			—			—
Gains (losses) on available-for-sale securities	—			—			—			—
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(7		)	(4		)	7			6
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	1			1			2			1
Gains (losses) on cash flow hedges	(6		)	(3		)	9			7
Total Other comprehensive income (loss)	$	70		$	105		$	17		$	(18	)

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

14

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the six months endedJune 30, 2017 and 2016 were as follows:

	2017						2016
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	160		$	221		$	86		$	88
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	—			—			—			—
Amortization of net actuarial loss, transition and prior service costs (1)	37			25			32			23
Retirement plans and other retiree benefits adjustments	37			25			32			23
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	—			—			—			—
Reclassification of (gains) losses into net earnings on available-for-sale securities	—			—			—			—
Gains (losses) on available-for-sale securities	—			—			—			—
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(20		)	(12		)	(7		)	(4		)
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(2		)	(1		)	—			—
Gains (losses) on cash flow hedges	(22		)	(13		)	(7		)	(4		)
Total Other comprehensive income (loss)	$	175		$	233		$	111		$	107

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

15

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

9. Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three and six months ended June 30, 2017 and 2016 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended June 30,
	2017			2016			2017			2016			2017		2016
Service cost	$	1		$	1		$	3		$	4		$	4	$	3
Interest cost	23			26			5			6			10		11
ESOP offset	—			—			—			—			—		(1		)
Expected return on plan assets	(28		)	(28		)	(5		)	(6		)	—		—
Amortization of transition and prior service costs (credits)	—			—			—			—			—		—
Amortization of actuarial loss (gain)	12			10			3			2			4		4
Net periodic benefit cost	$	8		$	9		$	6		$	6		$	18	$	17

	Pension Benefits												Other Retiree Benefits
	United States						International
	Six Months Ended June 30,
	2017			2016			2017			2016			2017		2016
Service cost	$	1		$	1		$	7		$	8		$	8	$	6
Interest cost	47			53			10			12			21		22
ESOP offset	—			—			—			—			—		(1		)
Expected return on plan assets	(55		)	(55		)	(10		)	(11		)	—		—
Amortization of transition and prior service costs (credits)	—			—			—			—			—		—
Amortization of actuarial loss (gain)	24			20			5			4			8		8
Net periodic benefit cost	$	17		$	19		$	12		$	13		$	37	$	35

For the six months endedJune 30, 2017, the Company made voluntary contributions of $57 to its U.S. postretirement plans. For the six months endedJune 30, 2016, the Company made voluntary contributions of $50 to its U.S. postretirement plans.

16

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

10.    Income Taxes

On March 30, 2016, the FASB issued ASU No. 2016-09, “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amended accounting for income taxes related to share-based compensation. As a result of adopting the standard effective January 1, 2017, the Company recognized excess tax benefits of $8 and $26 (resulting from an increase in the fair value of an award from the grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the three and six months ended June 30, 2017, respectively. These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits were recognized in equity. See Note 3, Recent Accounting Pronouncements for additional information.

Since 2002, the Company has taken a tax position in a foreign jurisdiction that has been challenged by the local tax authorities. In May 2015, the Company became aware of several rulings by the Supreme Court in this foreign jurisdiction disallowing certain tax deductions which had the effect of reversing prior decisions. The Company had taken deductions in prior years similar to those disallowed by such court and as a result, as required, reassessed its tax position and increased its unrecognized tax benefits in 2015.

During the quarter ended June 30, 2016, the Supreme Court in this foreign jurisdiction decided the matter in the Company’s favor for the years 2002 through 2005 and, as a result, the Company recorded a net tax benefit of $13, including interest. The Administrative Court in this jurisdiction has also decided the matter in the Company’s favor for the years 2008 through 2011 by acknowledging the Supreme Court’s ruling for the years 2002 through 2005, which eliminated the possibility for future appeals. The tax benefit of deductions related to this tax position taken for the years 2006 through 2007 and 2012 through 2014 totals approximately $15 at current exchange rates. These deductions are currently being challenged by the tax authorities either in the lower courts or at the administrative level and, if resolved in the Company’s favor, will result in the Company recording additional tax benefits, including interest.

11. Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, privacy, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $225 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

17

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $162. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. Appeals are currently pending at the administrative level. In the event the Company is ultimately unsuccessful in its administrative appeals, further appeals are available within the Brazilian federal courts.

In September 2015, the Company lost one of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a similar action in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.

In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $71, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal and the Company has filed a lawsuit in Brazilian federal court. In the event the Company is unsuccessful in this filing, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

18

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Competition Matters

Certain of the Company’s subsidiaries have been subject to investigations, and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also have involved other consumer goods companies and/or retail customers. These investigations often continue for several years and can result in substantial fines for violations that are found as well as associated private actions for damages. While the Company cannot predict the final financial impact of pending competition law matters, as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The current status of pending competition law matters as of June 30, 2017 (except as noted below) is set forth below.

▪ In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”), pursuant to a Business and Share Sale and Purchase Agreement (the “Sale and Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is entitled to indemnification for this fine from Unilever as provided in the Sale and Purchase Agreement. The fines were confirmed by the Court of Appeal in October 2016. The Company is appealing the decision of the Court of Appeal on behalf of the Company and Sara Lee in the French Supreme Court.

▪ In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11 (based on current exchange rates), which approximates reserves previously taken by the Company for this matter. The Company is currently reviewing the decision, and will likely appeal to the Greek courts.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of June 30, 2017, there were 174 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 146 cases as of March 31, 2017 and 115 cases as of December 31, 2016. During the three months endedJune 30, 2017, 36 new cases were filed and eight cases were resolved by voluntary dismissal or settlement. During the six months ended June 30, 2017, 77 new cases were filed and 18 cases were resolved by voluntary dismissal or settlement. The value of settlements in the quarter and the year-to-date period presented was not material, either individually or in the aggregate, to each such period’s results of operations.

A number of the pending cases are expected to go to trial in 2017. The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary and excess insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. Since the amount of any potential losses from these cases currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.

19

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

N8

The Company was a defendant in a lawsuit that was brought in Utah federal court by N8 Medical, Inc. (“N8 Medical”), Brigham Young University (“BYU”) and N8 Pharmaceuticals, Inc. (“N8 Pharma”). The complaint, originally filed in November 2013, alleged breach of contract and other torts arising out of the Company’s evaluation of a technology owned by BYU and licensed, at various times, to Ceragenix Pharmaceuticals, Inc., now in bankruptcy, N8 Medical and N8 Pharma.

In 2016, the Company resolved the claims brought by BYU and N8 Medical. These claims were each resolved in an amount that is not material to the Company’s results of operations. In the first quarter of 2017, the court dismissed the claims of N8 Pharma, which has filed a Notice of Appeal.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York. The Company Defendants filed a motion to dismiss this action, which was denied in February 2017. This action has not yet been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest, and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.

20

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

12.    Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

21

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016
Net sales
Oral, Personal and Home Care
North America	$	764		$	793		$	1,524		$	1,593
Latin America	1,002			938			1,926			1,786
Europe	584			606			1,142			1,194
Asia Pacific	663			697			1,383			1,440
Africa/Eurasia	241			239			487			470
Total Oral, Personal and Home Care	3,254			3,273			6,462			6,483
Pet Nutrition	572			572			1,126			1,124
Total Net sales	$	3,826		$	3,845		$	7,588		$	7,607
Operating profit
Oral, Personal and Home Care
North America	$	241		$	250		$	474		$	489
Latin America	308			284			577			531
Europe	145			138			285			279
Asia Pacific	205			219			424			438
Africa/Eurasia	45			45			90			88
Total Oral, Personal and Home Care	944			936			1,850			1,825
Pet Nutrition	163			162			320			317
Corporate	(254		)	(154		)	(432		)	(331		)
Total Operating profit	$	853		$	944		$	1,738		$	1,811

Approximately 75% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

For the three months endedJune 30, 2017, Corporate Operating profit (loss) included charges of $142 resulting from the 2012 Restructuring Program. For the six months endedJune 30, 2017, Corporate Operating profit (loss) included charges of $188 resulting from the 2012 Restructuring Program.

For the three months endedJune 30, 2016, Corporate Operating profit (loss) included charges of $59 resulting from the 2012 Restructuring Program. For the six months endedJune 30, 2016, Corporate Operating profit (loss) included charges of $114 resulting from the 2012 Restructuring Program.

For further information regarding the 2012 Restructuring Program, refer to Note 4, Restructuring and Related Implementation Charges.

22

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

13. Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

23

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at June 30, 2017 and December 31, 2016:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		6/30/17		12/31/16			6/30/17		12/31/16
Interest rate swap contracts	Other current assets	$	—	$	1	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	—		1		Other liabilities	1		—
Foreign currency contracts	Other current assets	13		29		Other accruals	28		4
Foreign currency contracts	Other assets	—		5		Other liabilities	26		—
Commodity contracts	Other current assets	—		—		Other accruals	—		—
Total designated		$	13	$	36		$	55	$	4
Derivatives not designated
Foreign currency contracts	Other current assets	$	—	$	—	Other accruals	$	1	$	—
Total not designated		$	—	$	—		$	1	$	—
Total derivative instruments		$	13	$	36		$	56	$	4
Other financial instruments
Marketable securities	Other current assets	$	144	$	23
Total other financial instruments		$	144	$	23

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of June 30, 2017 and December 31, 2016. The estimated fair value of the Company’s long-term debt, including the current portion, as of June 30, 2017 and December 31, 2016, was $6,710 and $6,717, respectively, and the related carrying value was $6,506 and $6,520, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

24

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Fair Value Hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting gain or loss on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net.

Activity related to fair value hedges recorded during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017									2016
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at June 30,	$	930		$	600		$	1,530		$	347		$	1,250		$	1,597
Three months ended June 30,
Gain (loss) on derivatives	(3		)	—			(3		)	(6		)	1			(5		)
Gain (loss) on hedged items	3			—			3			6			(1		)	5
Six months ended June 30,
Gain (loss) on derivatives	(1		)	(2		)	(3		)	(5		)	9			4
Gain (loss) on hedged items	1			2			3			5			(9		)	(4		)

Cash Flow Hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017								2016
	Foreign Currency Contracts			Commodity Contracts		Total			Foreign Currency Contracts			Commodity Contracts		Total
Notional Value at June 30,	$	719		$	2	$	721		$	705		$	9	$	714
Three months ended June 30,
Gain (loss) recognized in OCI	(7		)	—		(7		)	5			2		7
Gain (loss) reclassified into Cost of sales	(1		)	—		(1		)	(3		)	1		(2		)
Six months ended June 30,
Gain (loss) recognized in OCI	(20		)	—		(20		)	(9		)	2		(7		)
Gain (loss) reclassified into Cost of sales	2			—		2			—			—		—

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is generally expected to be recognized in Cost of sales within the next twelve months.

25

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Net Investment Hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Cumulative translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

Activity related to net investment hedges recorded during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017									2016
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at June 30,	$	800		$	572		$	1,372		$	895		$	1,280		$	2,175
Three months ended June 30,
Gain (loss) on instruments	(28		)	(78		)	(106		)	10			26			36
Gain (loss) on hedged items	27			78			105			(7		)	(26		)	(33		)
Six months ended June 30,
Gain (loss) on instruments	(46		)	(93		)	(139		)	(16		)	(23		)	(39		)
Gain (loss) on hedged items	47			93			140			16			23			39

Derivatives not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for the second quarter of 2017 include foreign currency contracts for which the gain or loss on the instrument is recognized in Other (income) expense, net for the three and six months ended June 30, 2017. During the second quarter of 2017, the Company de-designated foreign currency forward contracts previously designated as net investment hedges and entered into new derivative instruments with offsetting terms. Gains or losses on these de-designated derivatives were substantially offset by gains and losses on the new derivative instruments.

Derivatives not designated as hedging instruments for the second quarter of 2016 consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period.

Activity related to these contracts during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017		2016
	Foreign Currency Contracts		Foreign Currency Contracts
Notional Value at June 30,	$	48	$	5
Three months ended June 30,
Gain (loss) on instruments	—		2
Gain (loss) on hedged items	—		(2		)
Six months ended June 30,
Gain (loss) on instruments	—		5
Gain (loss) on hedged items	—		(5		)

26

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Other Financial Instruments

Other financial instruments are classified as Other current assets or Other assets.

Other financial instruments classified as Other current assets include marketable securities consisting of bank deposits of $144 with original maturities greater than 90 days carried at fair value (Level 1 valuation) and the current portion of bonds issued by the Argentinian government in the amount of $11 classified as held-to-maturity and carried at amortized cost.

Through its subsidiary in Argentina, the Company has invested in U.S. dollar-linked, devaluation-protected bonds issued by the Argentinian government. As of June 30, 2017, the amortized cost was $11 and their approximate fair value was $11 (Level 2 valuation).

27

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Executive Overview and Outlook

Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) seeks to deliver strong, consistent business results and superior shareholder returns by providing consumers globally with products that make their lives healthier and more enjoyable.

To this end, the Company is tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, the Company follows a closely defined business strategy to develop and increase market leadership positions in key product categories. These product categories are prioritized based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable long-term growth.

Operationally, the Company is organized along geographic lines with management teams having responsibility for the business and financial results in each region. The Company competes in more than 200 countries and territories worldwide with established businesses in all regions contributing to the Company’s sales and profitability. Approximately 75% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce the Company’s exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care product segment is managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell to a variety of retail and wholesale customers and distributors. The Company, through Hill’s Pet Nutrition, also competes on a worldwide basis in the pet nutrition market, selling its products principally through authorized pet supply retailers and veterinarians. The Company’s products are also sold online through various e-commerce platforms and retailers.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include market share, net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, and gross profit margin, operating profit, net income and earnings per share, in each case on a GAAP and non-GAAP basis, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. The monitoring of these indicators and the Company’s Code of Conduct and corporate governance practices help to maintain business health and strong internal controls. For additional information regarding non-GAAP financial measures, see “Non-GAAP Financial Measures” below.

To achieve its business and financial objectives, the Company focuses the organization on initiatives to drive and fund growth. The Company seeks to capture significant opportunities for growth by identifying and meeting consumer needs within its core categories, through its focus on innovation and the deployment of valuable consumer and shopper insights in the development of successful new products regionally, which are then rolled out on a global basis. To enhance these efforts, the Company has developed key initiatives to build strong relationships with consumers, dental and veterinary professionals and retail customers. In addition, the Company has strengthened its capabilities in e-commerce, developing its relationships with online-only retailers and its digital marketing capabilities. Growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for the Company’s products.

The investments needed to support growth are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as the Company’s funding-the-growth initiatives, the Company seeks to become even more effective and efficient throughout its businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics, and advertising and promotional materials, among other things, and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. The Company also continues to prioritize its investments toward its higher margin businesses, specifically Oral Care, Personal Care and Pet Nutrition.

28

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Effective December 31, 2015, the Company concluded it no longer met the accounting criteria for consolidation of its Venezuelan subsidiary (“CP Venezuela”) and began accounting for CP Venezuela using the cost method of accounting. As such, effective December 31, 2015, the Company’s Consolidated Balance Sheet no longer includes the assets and liabilities of CP Venezuela. Prior periods have not been restated and CP Venezuela’s Net sales, Operating profit and Net income are included in the Company’s Consolidated Statements of Income through December 31, 2015.

Since January 1, 2016, under the cost method of accounting, the Company no longer includes the local operating results of CP Venezuela in its Consolidated Financial Statements and includes income relating to CP Venezuela only to the extent it receives cash for sales of inventory to CP Venezuela or for dividends or royalties remitted by CP Venezuela, all of which have been immaterial. Although CP Venezuela’s local operating results are no longer included in the Company’s Consolidated Financial Statements for accounting purposes, under current tax rules, the Company is required to continue including CP Venezuela in its consolidated U.S. federal income tax return. In the first quarter of 2016, Provision for income taxes included a $210 U.S. income tax benefit principally related to changes in Venezuela’s foreign exchange regime implemented in March 2016.

In the fourth quarter of 2012, the Company commenced a Global Growth and Efficiency Program (as expanded in 2014 and 2015, as described below, the “2012 Restructuring Program”) for sustained growth. The program’s initiatives are expected to help the Company ensure sustained solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

On October 23, 2014, the Company’s Board of Directors (the “Board”) approved an expansion of the 2012 Restructuring Program to take advantage of additional savings opportunities. On October 29, 2015, the Board approved the reinvestment of the funds from the sale of the Company’s laundry detergent business in the South Pacific to expand the 2012 Restructuring Program and extend it through December 31, 2017. The Board approved the implementation plan for this expansion on March 10, 2016.

The initiatives under the 2012 Restructuring Program continue to be focused on the following areas:

▪ Expanding Commercial Hubs

▪ Extending Shared Business Services and Streamlining Global Functions

▪ Optimizing Global Supply Chain and Facilities

Implementation of the 2012 Restructuring Program remains on track. The Company continually seeks new projects and ways to advance the implementation of existing projects in order to accelerate savings under the program and, given the challenging market conditions and slowing category growth experienced in the first six months of 2017, it has identified additional opportunities and now estimates savings and charges to be at the upper end of its previously disclosed ranges. Savings, substantially all of which are expected to increase future cash flows, are now projected to be in the range of $455 to $495 pretax ($425 to $475 aftertax) annually, once all projects are approved and implemented, as compared to the previous estimate of $430 to $495 pretax ($400 to $475 aftertax). Cumulative pretax charges resulting from the 2012 Restructuring Program, once all phases are approved and implemented, are now estimated to be $1,500 to $1,585 ($1,120 to $1,170 aftertax) as compared to the previous estimate of $1,405 to $1,585 ($1,050 to $1,170 aftertax).

In the three and six months ended June 30, 2017, the Company incurred aftertax costs of $115 and $146, respectively, associated with the 2012 Restructuring Program.

For more information regarding the 2012 Restructuring Program, see “Restructuring and Related Implementation Charges” below.

29

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Looking forward, the Company expects global macroeconomic and market conditions to remain highly challenging and category growth rates to continue to be slow. While the global marketplace in which the Company operates has always been highly competitive, the Company continues to experience heightened competitive activity in certain markets from strong local competitors and from other large multinational companies, some of which have greater resources than the Company does. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. In addition, the emergence of new sales channels for the Company’s products, such as e-commerce, may affect consumer preferences and market dynamics. Given that approximately 75% of the Company’s Net sales originate in markets outside the U.S., the Company continues to experience volatile foreign currency fluctuations and high raw and packaging material costs, driven by foreign exchange transaction costs. While the Company has taken, and will continue to take, measures to mitigate the effect of these conditions, should they persist, they could adversely affect the Company’s future results. For additional information on factors that could impact the Company’s results, see “Cautionary Statement on Forward-Looking Statements” below.

The Company believes it is well prepared to meet the challenges ahead due to its strong financial condition, experience operating in challenging environments and continued focus on the Company’s strategic initiatives: engaging to build our brands; innovation for growth; effectiveness and efficiency; and leading to win. This focus, together with the strength of the Company’s global brands, its broad international presence in both developed and emerging markets and initiatives, such as the 2012 Restructuring Program, should position the Company well to increase shareholder value over the long term.

30

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Results of Operations

Three Months

Worldwide Net sales were $3,826 in the second quarter of 2017, down0.5% from the second quarter of 2016, as net selling price increases of 1.0% were more than offset by volume declines of 1.0% and negative foreign exchange of 0.5%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, were even with the second quarter of 2016. A reconciliation of net sales growth to organic sales growth is provided under “Non-GAAP Financial Measures” below.

Net sales in the Oral, Personal and Home Care product segment were $3,254 in the second quarter of 2017, down0.5% from the second quarter of 2016, as net selling price increases of 1.0% were more than offset by volume declines of 1.0% and negative foreign exchange of 0.5%. Organic sales in the Oral, Personal and Home Care product segment were even with the second quarter of 2016.

The Company’s share of the global toothpaste market was 43.6% on a year-to-date basis, down 0.2 share points from the year ago period, and its share of the global manual toothbrush market was 32.8% on a year-to-date basis, down 0.5 share points from the year ago period. Year-to-date market shares in toothpaste were up in Africa/Eurasia and down in North America, Latin America, Europe and Asia Pacific versus the comparable 2016 period. In the manual toothbrush category, year-to-date market shares were up in Africa/Eurasia and down in North America, Latin America, Europe and Asia Pacific versus the comparable 2016 period. For additional information regarding market shares, see “Market Share Information” below.

Net sales in the Hill’s Pet Nutrition segment were $572 in the second quarter of 2017, even with the second quarter of 2016, as net selling price increases of 2.0% were offset by volume declines of 1.5% and negative foreign exchange of 0.5%. Organic sales in the Hill’s Pet Nutrition segment increased0.5% in the second quarter of 2017.

31

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Gross Profit/Margin

Worldwide Gross profit decreased to $2,300 in the second quarter of 2017 from $2,304 in the second quarter of 2016. Gross profit in both periods included charges resulting from the 2012 Restructuring Program. Excluding these charges in both periods, Gross profit increased to $2,321 in the second quarter of 2017 from $2,316 in the second quarter of 2016. This increase in Gross profit reflects an increase of $17 resulting from higher Gross profit margin in the second quarter of 2017, partially offset by a decrease of $12, as a result of lower Net sales.

Worldwide Gross profit margin increased to 60.1% in the second quarter of 2017 from 59.9% in the second quarter of 2016. Excluding charges resulting from the 2012 Restructuring Program in both periods, Gross profit margin was 60.7% in the second quarter of 2017, an increase of 50 basis points (bps) from 60.2% in the second quarter of 2016. This increase in Gross profit margin was primarily driven by cost savings from the Company’s funding-the-growth initiatives (160 bps) and the 2012 Restructuring Program (10 bps), and higher pricing (40 bps), partially offset by higher raw and packaging material costs (180 bps), which included foreign exchange transaction costs.

	Three Months Ended June 30,
	2017		2016
Gross profit, GAAP	$	2,300	$	2,304
2012 Restructuring Program	21		12
Gross profit, non-GAAP	$	2,321	$	2,316

	Three Months Ended June 30,
	2017		2016		Basis Point Change
Gross profit margin, GAAP	60.1	%	59.9	%	20
2012 Restructuring Program	0.6		0.3
Gross profit margin, non-GAAP	60.7	%	60.2	%	50

32

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased1% to $1,333 in the second quarter of 2017 from $1,320 in the second quarter of 2016. Selling, general and administrative expenses in both periods included charges resulting from the 2012 Restructuring Program. Excluding these charges in both periods, Selling, general and administrative expenses increased to $1,316 in the second quarter of 2017 from $1,306 in the second quarter of 2016, reflecting increased advertising investment of $5 and higher overhead expenses of $5.

Selling, general and administrative expenses as a percentage of Net sales increased to 34.8% in the second quarter of 2017 from 34.3% in the second quarter of 2016. Excluding charges resulting from the 2012 Restructuring Program in both periods, Selling, general and administrative expenses as a percentage of Net sales increased by 40 bps to 34.4% in the second quarter of 2017 as compared to the second quarter of 2016. This increase was due to increased advertising investment (20 bps) and higher overhead expenses (20 bps), both as a percentage of Net sales. In the second quarter of 2017, advertising investment increased1% to $399, as compared with $394 in the second quarter of 2016, and increased as a percentage of Net sales to 10.4% in the second quarter of 2017 from 10.2% in the second quarter of 2016.

	Three Months Ended June 30,
	2017			2016
Selling, general and administrative expenses, GAAP	$	1,333		$	1,320
2012 Restructuring Program	(17		)	(14		)
Selling, general and administrative expenses, non-GAAP	$	1,316		$	1,306

	Three Months Ended June 30,
	2017		2016		Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP	34.8	%	34.3	%	50
2012 Restructuring Program	(0.4	)	(0.3	)
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP	34.4	%	34.0	%	40

Other (Income) Expense, Net

Other (income) expense, net was $114 in the second quarter of 2017, as compared to $40 in the second quarter of 2016. Other (income) expense, net in both periods included charges resulting from the 2012 Restructuring Program. Excluding these charges in both periods, Other (income) expense, net was $10 in the second quarter of 2017, as compared to $7 in the second quarter of 2016.

	Three Months Ended June 30,
	2017			2016
Other (income) expense, net, GAAP	$	114		$	40
2012 Restructuring Program	(104		)	(33		)
Other (income) expense, net, non-GAAP	$	10		$	7

33

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Operating Profit

Operating profit decreased10% to $853 in the second quarter of 2017 from $944 in the second quarter of 2016. Operating profit in both periods included charges resulting from the 2012 Restructuring Program. Excluding these charges in both periods, Operating profit was $995 in the second quarter of 2017, compared to $1,003 in the second quarter of 2016, a decrease of 1%, as an increase in Gross profit was offset by an increase in Selling, general and administrative expenses.

Operating profit margin was 22.3% in the second quarter of 2017, a decrease of 230 bps compared to 24.6% in the second quarter of 2016. Excluding charges resulting from the 2012 Restructuring Program in both periods, Operating profit margin was 26.0% in the second quarter of 2017, a decrease of 10 bps as compared to 26.1% in the second quarter of 2016, as an increase in Gross profit margin (50 bps) was more than offset by an increase in Selling, general and administrative expenses (40 bps) and Other (income) expense, net (20 bps), all as a percentage of Net sales.

	Three Months Ended June 30,
	2017		2016		% Change
Operating profit, GAAP	$	853	$	944	(10	)%
2012 Restructuring Program	142		59
Operating profit, non-GAAP	$	995	$	1,003	(1	)%

	Three Months Ended June 30,
	2017		2016		Basis Point Change
Operating profit margin, GAAP	22.3	%	24.6	%	(230	)
2012 Restructuring Program	3.7		1.5
Operating profit margin, non-GAAP	26.0	%	26.1	%	(10	)

Interest (Income) Expense, Net

Interest (income) expense, net was $24 in the second quarter of 2017 as compared to $25 in the second quarter of 2016, primarily due to higher interest income on investments held outside the United States.

34

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share

Net income attributable to Colgate-Palmolive Company for the second quarter of 2017decreased to $524 from $600 in the second quarter of 2016, and Earnings per common share on a diluted basis decreased to $0.59 per share in the second quarter of 2017 from $0.67 in the second quarter of 2016. Net income attributable to Colgate-Palmolive Company in both periods included charges resulting from the 2012 Restructuring Program. Net income attributable to Colgate-Palmolive Company in the second quarter of 2016 also included a net benefit related to a previously disclosed foreign tax matter (see “Income taxes” below for further information).

Excluding the items described above in both periods as applicable, Net income attributable to Colgate-Palmolive Company in the second quarter of 2017increased1% to $639, and Earnings per common share on a diluted basis increased3% to $0.72 in the second quarter of 2017 from $0.70 in the second quarter of 2016.

	Three Months Ended June 30, 2017
	Income Before Income Taxes		Provision For Income Taxes(1)		Net Income Including Noncontrolling Interests		Net Income Attributable To Colgate-Palmolive Company		Diluted Earnings Per Share(2)
As Reported GAAP	$	829	$	269	$	560	$	524	$	0.59
2012 Restructuring Program	142		27		115		115		0.13
Non-GAAP	$	971	$	296	$	675	$	639	$	0.72

	Three Months Ended June 30, 2016
	Income Before Income Taxes		Provision For Income Taxes(1)		Net Income Including Noncontrolling Interests			Less: Income Attributable to Noncontrolling Interests		Net Income Attributable To Colgate-Palmolive Company			Diluted Earnings Per Share(2)
As Reported GAAP	$	919	$	281	$	638		$	38	$	600		$	0.67
2012 Restructuring Program	59		14		45			1		44			0.05
Benefit from a previously disclosed foreign tax matter, net	—		13		(13		)	—		(13		)	(0.01		)
Non-GAAP	$	978	$	308	$	670		$	39	$	631		$	0.70

⁽¹⁾ The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

⁽²⁾ The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

35

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Net Sales and Operating Profit by Segment

Oral, Personal and Home Care

North America

	Three Months Ended June 30,
	2017			2016			Change
Net sales	$	764		$	793		(3.5	)	%
Operating profit	$	241		$	250		(4	)	%
% of Net sales	31.5		%	31.5		%	—		bps

Net sales in North America decreased3.5% in the second quarter of 2017 to $764, driven by volume declines of 2.0% and net selling price decreases of 1.5%, while foreign exchange was flat. Organic sales in North America decreased3.5% in the second quarter of 2017.

The decrease in organic sales in North America in the second quarter of 2017 versus the second quarter of 2016 was primarily

due to a decrease in Oral Care and Home Care organic sales. The decrease in Oral Care organic sales was attributable to a decline in organic sales in the manual toothbrush category. The decrease in Home Care organic sales was attributable to a decline in organic sales in the hand dish category.

Operating profit in North America decreased4% in the second quarter of 2017 to $241, while as a percentage of Net sales it remained even at 31.5% as a decrease in Gross profit (20 bps) and an increase in Selling, general and administrative expenses (20 bps) were offset by a decrease in Other (income) expense, net (40 bps), all as a percentage of Net sales. This decrease in Gross profit was primarily driven by higher raw and packaging material costs (140 bps), which included foreign exchange transaction costs, and lower pricing, partially offset by cost savings from the Company’s funding-the-growth initiatives (160 bps) and the 2012 Restructuring Program (30 bps). This increase in Selling, general and administrative expenses was due to higher overhead expenses (30 bps), which were partially offset by a decrease in advertising investment (10 bps). This decrease in advertising investment in part reflects a shift from advertising investment to in-store promotional activities and the timing of advertising spending in the prior year.

36

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Latin America

	Three Months Ended June 30,
	2017			2016			Change
Net sales	$	1,002		$	938		7.0	%
Operating profit	$	308		$	284		8	%
% of Net sales	30.7		%	30.3		%	40	bps

Net sales in Latin America increased7.0% to $1,002 in the second quarter of 2017, driven by net selling price increases of 4.5% and volume growth of 2.5%, while foreign exchange was flat. Organic sales in Latin America increased 7.0% in the second quarter of 2017. Volume gains were led by Brazil, the Andean Region and Argentina.

The increase in organic sales in Latin America in the second quarter of 2017 versus the second quarter of 2016 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care organic sales was driven by organic sales growth in the toothpaste category. Personal Care organic sales growth was driven by organic sales growth in the bar soap category. The increase in Home Care organic sales was due to organic sales growth in the fabric softener and liquid cleaners categories.

Operating profit in Latin America increased8% in the second quarter of 2017 to $308, or 40 bps to 30.7% of Net sales. This increase in Operating profit as a percentage of Net sales was due to an increase in Gross profit (70 bps) and a decrease in Other (income) expense, net (40 bps), partially offset by an increase in Selling, general and administrative expenses (70 bps), all as a percentage of Net sales. This increase in Gross profit was due to cost savings from the Company’s funding-the-growth initiatives (140 bps), and higher pricing, partially offset by higher raw and packaging material costs (290 bps), which included foreign exchange transaction costs. This increase in Selling, general and administrative expenses was primarily due to an increase in advertising investment (60 bps). 

37

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Europe

	Three Months Ended June 30,
	2017			2016			Change
Net sales	$	584		$	606		(3.5	)	%
Operating profit	$	145		$	138		5		%
% of Net sales	24.8		%	22.8		%	200		bps

Net sales in Europe decreased3.5% in the second quarter of 2017 to $584. Net selling price increases of 0.5% were more than offset by volume declines of 1.0% and negative foreign exchange of 3.0%. Organic sales in Europe decreased 0.5% in the second quarter of 2017. Volume declines in Germany and Norway were partially offset by volume gains in the Netherlands, the United Kingdom and Poland.

The decrease in organic sales in Europe in the second quarter of 2017 versus the second quarter of 2016 was primarily due to a decrease in organic sales in the Personal Care category, partially offset by an increase in organic sales in the Oral Care category. The decrease in Personal Care organic sales was due to a decline in organic sales in the liquid hand soap, bar soap and shampoo categories, partially offset by growth in the shower gel category. The increase in Oral Care organic sales was due to organic sales in the toothpaste category.

Operating profit in Europe increased5% in the second quarter of 2017 to $145, or 200 bps to 24.8% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (50 bps) and a decrease in Selling, general and administrative expenses (190 bps), both as a percentage of Net sales. This increase in Gross profit was primarily driven by cost savings from the Company’s funding-the-growth initiatives (210 bps) and the 2012 Restructuring Program (20 bps), and sales mix, partially offset by higher raw and packaging material costs (230 bps), which included foreign exchange transaction costs. This decrease in Selling, general and administrative expenses was due to lower overhead expenses (170 bps) and a slight decrease in advertising investment (20 bps).

Asia Pacific

	Three Months Ended June 30,
	2017			2016			Change
Net sales	$	663		$	697		(5.0	)	%
Operating profit	$	205		$	219		(6	)	%
% of Net sales	30.9		%	31.4		%	(50	)	bps

Net sales in Asia Pacific decreased5.0% in the second quarter of 2017 to $663, driven by volume declines of 2.0%, net selling price decreases of 1.5% and negative foreign exchange of 1.5%. Organic sales in Asia Pacific decreased 3.5% in the second quarter of 2017. Volume declines in India, Thailand and Australia were partially offset by volume gains in the Philippines, Vietnam and New Zealand.

The decrease in organic sales in Asia Pacific in the second quarter of 2017 versus the second quarter of 2016 was driven by Oral Care with declines in organic sales in the toothpaste and manual toothbrush categories. Personal Care also contributed to the organic sales decline with decreased organic sales in the shampoo category.

Operating profit in Asia Pacific decreased6% to $205 in the second quarter of 2017, or 50 bps to 30.9% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit (130 bps), partially offset by a decrease in Selling, general and administrative expenses (60 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily driven by higher raw and packaging material costs (300 bps), which included foreign exchange transaction costs, and lower pricing, partially offset by cost savings from the Company’s funding-the-growth initiatives (230 bps). This decrease in Selling, general and administrative expenses was due to decreased advertising investment (80 bps), in part reflecting a shift from advertising investment to in-store promotional activities and also due to the timing of advertising spending in the prior year, which was partially offset by higher overhead expenses (20 bps).

38

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Africa/Eurasia

	Three Months Ended June 30,
	2017			2016			Change
Net sales	$	241		$	239		1.0		%
Operating profit	$	45		$	45		—		%
% of Net sales	18.7		%	18.8		%	(10	)	bps

Net sales in Africa/Eurasia increased1.0% in the second quarter of 2017 to $241. Net selling price increases of 4.5% and the impact of positive foreign exchange of 4.0% were partially offset by volume declines of 7.5%. Organic sales in Africa/Eurasia decreased 3.0% in the second quarter of 2017. Volume declines in the Sub-Saharan Africa region, Turkey and South Africa were partially offset by volume gains in Russia.

The decrease in organic sales in Africa/Eurasia in the second quarter of 2017 versus the second quarter of 2016 was due to a decrease in Personal Care and Home Care organic sales. The decrease in Personal Care was due to a decline in organic sales in the shower gel category. The decrease in Home Care was due to a decline in organic sales in the liquid cleaners and hand dish categories.

Operating profit in Africa/Eurasia was $45 in the second quarter of 2017, even with the second quarter of 2016, while as a percentage of Net sales it decreased 10 bps to 18.7%. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (320 bps), which was more than offset by an increase in Selling, general and administrative expenses (380 bps), both as a percentage of Net sales. This increase in Gross profit was mainly driven by cost savings from the Company’s funding-the-growth initiatives (120 bps), and higher pricing, partially offset by higher raw and packaging material costs (40 bps). This increase in Selling, general and administrative expenses was due to increased advertising investment (420 bps), partially offset by lower overhead expenses (40 bps).

Hill’s Pet Nutrition

	Three Months Ended June 30,
	2017			2016			Change
Net sales	$	572		$	572		—	%
Operating profit	$	163		$	162		1	%
% of Net sales	28.5		%	28.3		%	20	bps

Net sales for Hill’s Pet Nutrition were $572 in the second quarter of 2017, even with the second quarter of 2016 as net selling price increases of 2.0% were offset by volume declines of 1.5% and negative foreign exchange of 0.5%. Organic sales in Hill’s Pet Nutrition increased 0.5% in the second quarter of 2017. Volume declines in the United States, Japan and Canada were partially offset by volume gains in Russia, Latin America and South Africa. The volume declines in Japan are attributable to a continued contraction in the market.

The increase in organic sales in the second quarter of 2017 versus the second quarter of 2016 was due to an increase in organic sales in the Prescription Diet category, partially offset by a decline in organic sales in the Advanced Nutrition and Naturals categories.

Operating profit in Hill’s Pet Nutrition increased1% in the second quarter of 2017 to $163, or 20 bps to 28.5% of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (150 bps), partially offset by an increase in Selling, general and administrative expenses (90 bps), both as a percentage of Net sales. This increase in Gross profit was mainly driven by cost savings from the Company’s funding-the-growth initiatives (140 bps), and higher pricing, partially offset by higher costs (30 bps), which were primarily driven by higher raw and packaging material costs, which included foreign exchange transaction costs. This increase in Selling, general and administrative expenses was due to higher overhead expenses (60 bps) and increased advertising investment (30 bps).

39

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Corporate

	Three Months Ended June 30,
	2017			2016			Change
Operating profit (loss)	$	(254	)	$	(154	)	65	%

Operating profit (loss) related to Corporate was ($254) in the second quarter of 2017 as compared to ($154) in the second quarter of 2016. In the second quarter of 2017, Corporate Operating profit (loss) included charges of $142 resulting from the 2012 Restructuring Program. In the second quarter of 2016, Corporate Operating profit (loss) included charges of $59 resulting from the 2012 Restructuring Program.

Six Months

Worldwide Net sales were $7,588 in the first six months of 2017, a decrease of $19 as compared to the first six months of 2016, as net selling price increases of 1.5% were offset by volume declines of 1.5%, while foreign exchange was flat. Organic sales in the first six months of 2017 were even with the first six months of 2016.

Net sales in the Oral, Personal and Home Care product segment were $6,462 in the first six months of 2017, a decrease of 0.5% from the first six months of 2016, as net selling price increases of 1.5% were more than offset by volume declines of 1.5% and negative foreign exchange of 0.5%. Organic sales in the Oral, Personal and Home Care product segment in the first six months of 2017 were even with the first six months of 2016.

Organic sales in the Oral, Personal and Home Care product segment in the first six months of 2017 were even with the first six months of 2016 as an increase in Oral Care organic sales was offset by a decrease in organic sales in Personal Care and Home Care. The increase in Oral Care organic sales was due to growth in the toothpaste category. The decrease in Personal Care organic sales was attributable to declines in the liquid hand soap and underarm protection categories. The decrease in Home Care organic sales was attributable to declines in the hand dish category, partially offset by gains in the fabric softener category.

Net sales in the Hill’s Pet Nutrition segment were $1,126 in the first six months of 2017, an increase of $2 as compared to the first six months of 2016, as net selling price increases of 2.5% were offset by volume declines of 2.5%, while foreign exchange was flat. Organic sales for the Hill’s Pet Nutrition segment in the first six months of 2017 were even with the first six months of 2016 as organic sales growth in the Prescription Diet category was offset by a decline in organic sales in the Naturals and Advanced Nutrition categories.

40

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Net Sales and Operating Profit by Segment

Net sales and Operating profit by segment were as follows:

	Six Months Ended June 30,
	2017			2016
Net sales
Oral, Personal and Home Care
North America	$	1,524		$	1,593
Latin America	1,926			1,786
Europe	1,142			1,194
Asia Pacific	1,383			1,440
Africa/Eurasia	487			470
Total Oral, Personal and Home Care	6,462			6,483
Pet Nutrition	1,126			1,124
Total Net sales	$	7,588		$	7,607
Operating profit
Oral, Personal and Home Care
North America	$	474		$	489
Latin America	577			531
Europe	285			279
Asia Pacific	424			438
Africa/Eurasia	90			88
Total Oral, Personal and Home Care	1,850			1,825
Pet Nutrition	320			317
Corporate	(432		)	(331		)
Total Operating profit	$	1,738		$	1,811

Within the Oral, Personal and Home Care product segment, North America Net sales decreased4.5%, as a result of volume declines of 3.5% and net selling price decreases of 1.0%, while foreign exchange was flat. Organic sales in North America decreased4.5%. Latin America Net sales increased8.0%, driven by net selling price increases of 5.5%, volume growth of 1.5% and positive foreign exchange of 1.0%. Organic sales in Latin America increased7.0%. Europe Net sales decreased4.5%, as a result of net selling price decreases of 0.5% and negative foreign exchange of 4.0%, while volume was flat. Organic sales in Europe decreased0.5%. Asia Pacific Net sales decreased4.0%, as a result of volume declines of 2.0%, net selling price decreases of 0.5% and negative foreign exchange of 1.5%. Organic sales in Asia Pacific decreased2.5%. Africa/Eurasia Net sales increased3.5%, as net selling price increases of 6.0% and positive foreign exchange of 4.5% were partially offset by volume declines of 7.0%. Organic sales in Africa/Eurasia decreased1.0%.

In the first six months of 2017, Operating profit (loss) related to Corporate was ($432) as compared to ($331) in the first six months of 2016. In the first six months of 2017 and 2016, Corporate Operating profit (loss) included charges of $188 and $114, respectively, resulting from the 2012 Restructuring Program.

41

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Gross Profit/Margin

Worldwide Gross profit increased to $4,569 in the first six months of 2017 from $4,552 in the first six months of 2016. Gross profit in both periods included charges resulting from the 2012 Restructuring Program. Excluding these charges in both periods, Gross profit increased to $4,604 in the first six months of 2017 from $4,572 in the first six months of 2016. This increase in Gross profit reflects an increase of $44 resulting from higher Gross profit margin in the first six months of 2017, partially offset by a decrease of $12, as a result of lower Net sales.

Worldwide Gross profit margin was 60.2% in the first six months of 2017 as compared to 59.8% in the first six months of 2016. Excluding the charges resulting from the 2012 Restructuring Program in both periods, Gross profit margin increased by 60 bps to 60.7% in the first six months of 2017, from 60.1% in the first six months of 2016, primarily driven by cost savings from the Company’s funding-the-growth initiatives (150 bps), and higher pricing (60 bps), which were partially offset by higher costs (130 bps), driven by higher raw and packaging material costs, which included foreign exchange transaction costs.

	Six Months Ended June 30,
	2017		2016
Gross profit, GAAP	$	4,569	$	4,552
2012 Restructuring Program	35		20
Gross profit, non-GAAP	$	4,604	$	4,572

	Six Months Ended June 30,
	2017		2016		Basis Point Change
Gross profit margin, GAAP	60.2	%	59.8	%	40
2012 Restructuring Program	0.5		0.3
Gross profit margin, non-GAAP	60.7	%	60.1	%	60

42

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased1% to $2,695 in the first six months of 2017 from $2,674 in the first six months of 2016. Selling, general and administrative expenses in both periods included charges resulting from the 2012 Restructuring Program. Excluding these charges, Selling, general and administrative expenses increased to $2,657 in the first six months of 2017 from $2,634 in the first six months of 2016, reflecting higher overhead expenses of $16 and increased advertising investment of $7.

Selling, general and administrative expenses as a percentage of Net sales increased to 35.5% in the first six months of 2017 from 35.2% in the first six months of 2016. Excluding charges resulting from the 2012 Restructuring Program, Selling, general and administrative expenses as a percentage of Net sales were 35.0% in the first six months of 2017, an increase of 40 bps as compared to the first six months of 2016. This increase was a result of higher overhead expenses (30 bps) and increased advertising investment (10 bps), both as a percentage of Net sales. In the first six months of 2017, advertising investment increased1% to $799, as compared with $792 in the first six months of 2016, while as a percentage of Net sales it increased to 10.5% in the first six months of 2017 from 10.4% in the first six months of 2016.

	Six Months Ended June 30,
	2017			2016
Selling, general and administrative expenses, GAAP	$	2,695		$	2,674
2012 Restructuring Program	(38		)	(40		)
Selling, general and administrative expenses, non-GAAP	$	2,657		$	2,634

	Six Months Ended June 30,
	2017		2016		Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP	35.5	%	35.2	%	30
2012 Restructuring Program	(0.5	)	(0.6	)
Selling, general and administrative expenses as a percentage of Net sales, non- GAAP	35.0	%	34.6	%	40

Other (Income) Expense, Net

Other (income) expense, net was $136 in the first six months of 2017, as compared to $67 in the first six months of 2016.

Other (income) expense, net in both periods included charges resulting from the 2012 Restructuring Program. Excluding these charges in both periods, Other (income) expense, net was $21 in the first six months of 2017, as compared to $13 in the first six months of 2016.

	Six Months Ended June 30,
	2017			2016
Other (income) expense, net, GAAP	$	136		$	67
2012 Restructuring Program	(115		)	(54		)
Other (income) expense, net, non-GAAP	$	21		$	13

43

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Operating Profit

Operating profit decreased to $1,738 in the first six months of 2017 from $1,811 in the first six months of 2016. Operating profit in both periods included charges resulting from the 2012 Restructuring Program. Excluding these charges in both periods, Operating profit for the first six months of 2017 increased to $1,926 from $1,925 in the first six months of 2016, primarily due to higher Gross profit, partially offset by an increase in Selling, general and administrative expenses.

Operating profit margin was 22.9% in the first six months of 2017, a decrease of 90 bps compared to 23.8% in the first six months of 2016. Excluding the charges resulting from the 2012 Restructuring Program in both periods, Operating profit margin was 25.4%, an increase of 10 bps from 25.3% in the first six months of 2016. This increase was primarily due to an increase in Gross profit margin (60 bps), partially offset by an increase in Selling, general and administrative expenses as a percentage of Net sales (40 bps).

	Six Months Ended June 30,
	2017		2016		% Change
Operating profit, GAAP	$	1,738	$	1,811	(4	)%
2012 Restructuring Program	188		114
Operating profit, non-GAAP	$	1,926	$	1,925	—	%

	Six Months Ended June 30,
	2017		2016		Basis Point Change
Operating profit margin, GAAP	22.9	%	23.8	%	(90	)
2012 Restructuring Program	2.5		1.5
Operating profit margin, non-GAAP	25.4	%	25.3	%	10

Interest (Income) Expense, Net

Interest (income) expense, net was $47 in the first six months of 2017 as compared to $53 in the first six months of 2016, primarily due to lower interest expense as a result of lower average debt balances and higher interest income on investments held outside the United States.

44

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Income Taxes

The effective tax rate was 32.4% for the second quarter of 2017 as compared to 30.6% for the second quarter of 2016. As reflected in the table below, the non-GAAP income tax rate was 30.5% for the quarter ended June 30, 2017, as compared to 31.5% in the comparable period of 2016. The decrease in the non-GAAP effective tax rate in the second quarter of 2017 was primarily due to the recognition of $8 of excess tax benefits in the Provision for income taxes in the second quarter of 2017 following the adoption of ASU No. 2016-09, “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” effective January 1, 2017. See Note 3, Recent Accounting Pronouncements and Note 10, Income Taxes to the Condensed Consolidated Financial Statements, for additional details.

The effective tax rate was 30.8% for the first six months of 2017 as compared to 31.1% for the first six months of 2016. As reflected in the table below, the non-GAAP income tax rate was 29.9% for the first six months ended June 30, 2017, as compared to 31.5% in the comparable period of 2016. The decrease in the non-GAAP effective tax rate in the first six months of 2017 was primarily due to the recognition of $26 of excess tax benefits in the Provision for income taxes during the first six months of 2017, as a result of the adoption of the new accounting guidance discussed above.

The quarterly provision for income taxes is determined based on the Company’s estimated full year effective tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. In addition, as discussed above, effective January 1, 2017, excess tax benefits from share-based compensation are now recognized in the Provision for income taxes on a discrete basis. The Company’s current estimate of its full year effective income tax rate before discrete period items is 31.3%, compared to 31.5% in the second quarter of 2016.

	Three Months Ended June 30,
	2017						2016
	Income Before Income Taxes		Provision For Income Taxes(1)		Effective Income Tax Rate(2)		Income Before Income Taxes		Provision For Income Taxes(1)		Effective Income Tax Rate(2)
As Reported GAAP	$	829	$	269	32.4	%	$	919	$	281	30.6	%
2012 Restructuring Program	142		27		(1.9	)	59		14		(0.4	)
Benefit from a previously disclosed foreign tax matter, net	—		—		—		—		13		1.3
Non-GAAP	$	971	$	296	30.5	%	$	978	$	308	31.5	%

	Six Months Ended June 30,
	2017						2016
	Income Before Income Taxes		Provision For Income Taxes(1)		Effective Income Tax Rate(2)		Income Before Income Taxes		Provision For Income Taxes(1)		Effective Income Tax Rate(2)
As Reported GAAP	$	1,691	$	520	30.8	%	$	1,758	$	546	31.1	%
2012 Restructuring Program	188		42		(0.9	)	114		31		(0.2	)
Benefit from a previously disclosed foreign tax matter, net	—		—		—		—		13		0.6
Non-GAAP	$	1,879	$	562	29.9	%	$	1,872	$	590	31.5	%

⁽¹⁾ The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

⁽²⁾ The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

45

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Since 2002, the Company has taken a tax position in a foreign jurisdiction that has been challenged by the local tax authorities. In May 2015, the Company became aware of several rulings by the Supreme Court in this foreign jurisdiction disallowing certain tax deductions, which had the effect of reversing prior decisions. The Company had taken deductions in prior years similar to those disallowed by such court and, as a result, as required, reassessed its tax position and increased its unrecognized tax benefits in 2015.

During the quarter ended June 30, 2016, the Supreme Court in this foreign jurisdiction decided the matter in the Company’s favor for the years 2002 through 2005 and, as a result, the Company recorded a net tax benefit of $13, including interest. The Administrative Court in this jurisdiction has also decided the matter in the Company’s favor for the years 2008 through 2011 by acknowledging the Supreme Court’s ruling for the years 2002 through 2005, which eliminated the possibility for future appeals. The tax benefit of deductions related to this tax position taken for the years 2006 through 2007 and 2012 through 2014 totals approximately $15 at current exchange rates. These deductions are currently being challenged by the tax authorities either in the lower courts or at the administrative level and, if resolved in the Company’s favor, will result in the Company recording additional tax benefits, including interest.

Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share

Net income attributable to Colgate-Palmolive Company in the first six months of 2017decreased to $1,094 from $1,133 in the comparable 2016 period. Earnings per common share on a diluted basis decreased to $1.23 per share from $1.26 per share in the comparable 2016 period. Net income attributable to Colgate-Palmolive Company in both periods included charges resulting from the 2012 Restructuring Program. Net income attributable to Colgate-Palmolive Company in the first six months of 2016 also included a net benefit related to a previously disclosed foreign tax matter.

Excluding the items described above in both periods, as applicable, Net income attributable to Colgate-Palmolive Company increased3% to $1,240 in the first six months of 2017 from $1,202 in the first six months of 2016 and Earnings per common share on a diluted basis increased5% to $1.39 in the first six months of 2017 from $1.33 in the first six months of 2016.

	Six Months Ended June 30, 2017
	Income Before Income Taxes		Provision For Income Taxes(1)		Net Income Including Noncontrolling Interests		Net Income Attributable To Colgate-Palmolive Company		Diluted Earnings Per Share(2)
As Reported GAAP	$	1,691	$	520	$	1,171	$	1,094	$	1.23
2012 Restructuring Program	188		42		146		146		0.16
Non-GAAP	$	1,879	$	562	$	1,317	$	1,240	$	1.39

	Six Months Ended June 30, 2016
	Income Before Income Taxes		Provision For Income Taxes(1)		Net Income Including Noncontrolling Interests			Less: Income Attributable To Noncontrolling Interests		Net Income Attributable To Colgate-Palmolive Company			Diluted Earnings Per Share(2)
As Reported GAAP	$	1,758	$	546	$	1,212		$	79	$	1,133		$	1.26
2012 Restructuring Program	114		31		83			1		82			0.09
Benefit from a previously disclosed foreign tax matter, net	—		13		(13		)	—		(13		)	(0.01		)
Non-GAAP	$	1,872	$	590	$	1,282		$	80	$	1,202		$	1.33

⁽¹⁾ The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

⁽²⁾ The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

46

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Restructuring and Related Implementation Charges

2012 Restructuring Program

In the fourth quarter of 2012, the Company commenced the 2012 Restructuring Program. The program’s initiatives are expected to help Colgate ensure sustained solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

The 2012 Restructuring Program is expected to produce significant benefits in the Company’s long-term business performance. The major objectives of the program include:

▪ Becoming even stronger on the ground through the continued evolution and expansion of proven global and regional commercial capabilities, which have already been successfully implemented in a number of the Company’s operations around the world.

▪ Simplifying and standardizing how work gets done by increasing technology-enabled collaboration and taking advantage of global data and analytic capabilities, leading to smarter and faster decisions.

▪ Reducing structural costs to continue to increase the Company’s gross and operating profit.

▪ Building on Colgate’s current position of strength to enhance its leading market share positions worldwide and ensure sustained sales and earnings growth.

On October 23, 2014, the Board approved an expansion of the 2012 Restructuring Program to take advantage of additional savings opportunities. On October 29, 2015, the Board approved the reinvestment of the funds from the sale of the Company’s laundry detergent business in the South Pacific to expand the 2012 Restructuring Program and extend it through December 31, 2017. The Board approved the implementation plan for this expansion on March 10, 2016.

The initiatives under the 2012 Restructuring Program continue to be focused on the following areas:

▪ Expanding Commercial Hubs – Building on the success of this structure already implemented in several divisions, continuing to cluster single-country subsidiaries into more efficient regional hubs, in order to drive smarter and faster decision-making, strengthen capabilities available on the ground and improve cost structure.

▪ Extending Shared Business Services and Streamlining Global Functions – Implementing the Company’s shared service organizational model in all regions of the world. While initially focused on finance and accounting, these shared services are now being expanded to additional functional areas to streamline global functions.

▪ Optimizing Global Supply Chain and Facilities – Continuing to optimize manufacturing efficiencies, global warehouse networks and office locations for greater efficiency, lower cost and speed to bring innovation to market.

Implementation of the 2012 Restructuring Program remains on track. The Company continually seeks new projects and ways to advance the implementation of existing projects in order to accelerate savings under the program and, given the challenging market conditions and slowing category growth experienced in the first six months of 2017, it has identified additional opportunities and now estimates savings and charges to be at the upper end of its previously disclosed ranges. Savings, substantially all of which are expected to increase future cash flows, are now projected to be in the range of $455 to $495 pretax ($425 to $475 aftertax) annually, once all projects are approved and implemented, as compared to the previous estimate of $430 to $495 pretax ($400 to $475 aftertax). Savings in 2017 are now expected to amount to approximately $50 to $60 pretax ($40 to $50 aftertax) as compared to the previous estimate of $40 to $60 pretax ($30 to $50 aftertax). Cumulative pretax charges resulting from the 2012 Restructuring Program, once all phases are approved and implemented, are now estimated to be $1,500 to $1,585 ($1,120 to $1,170 aftertax) as compared to the previous estimate of $1,405 to $1,585 ($1,050 to $1,170 aftertax).

47

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

The pretax charges resulting from the 2012 Restructuring Program are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (45%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of related implementation charges resulting directly from exit activities (20%) and the implementation of new strategies (25%). Over the course of the 2012 Restructuring Program, it is currently estimated that approximately 75% of the charges will result in cash expenditures. Anticipated pretax charges for 2017 are now expected to approximate $275 to $360 ($210 to $260 aftertax) as compared to the previous estimate of $180 to $360 ($140 to $260 aftertax). It is expected that substantially all charges resulting from the 2012 Restructuring Program will be incurred by December 31, 2017.

It is currently expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe (25%), Latin America (5%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (5%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that, when it has been fully implemented, the 2012 Restructuring Program will contribute a net reduction of approximately 3,300 to 3,800 positions from the Company’s global employee workforce.

For the three and six months ended June 30, 2017 and 2016, restructuring and related implementation charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Cost of sales	$	21	$	12	$	35	$	20
Selling, general and administrative expenses	17		14		38		40
Other (income) expense, net	104		33		115		54
Total 2012 Restructuring Program charges, pretax	$	142	$	59	$	188	$	114
Total 2012 Restructuring Program charges, aftertax	$	115	$	44	$	146	$	82

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:

	Three Months Ended				Six Months Ended				Program-to-date
	June 30,				June 30,				Accumulated Charges
	2017		2016		2017		2016
North America	17	%	23	%	22	%	32	%	17	%
Latin America	3	%	6	%	3	%	7	%	4	%
Europe	55	%	6	%	42	%	7	%	24	%
Asia Pacific	3	%	9	%	3	%	6	%	3	%
Africa/Eurasia	2	%	22	%	2	%	15	%	6	%
Hill’s Pet Nutrition	2	%	17	%	4	%	9	%	7	%
Corporate	18	%	17	%	24	%	24	%	39	%

48

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,416 ($1,053 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of June 30, 2017
Employee-Related Costs	$	573
Incremental Depreciation	86
Asset Impairments	29
Other	728
Total	$	1,416

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the extension of shared business services and streamlining of global functions; the consolidation of facilities; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; and restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan.

The following tables summarize the activity for the restructuring and related implementation charges discussed above and the related accruals:

	Three Months Ended June 30, 2017
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at March 31, 2017	$	44		$	—		$	—	$	123		$	167
Charges	100			4			—		38			142
Cash payments	(8		)	—			—		(46		)	(54		)
Charges against assets	(1		)	(4		)	—		—			(5		)
Foreign exchange	3			—			—		1			4
Balance at June 30, 2017	$	138		$	—		$	—	$	116		$	254

	Six Months Ended June 30, 2017
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2016	$	56		$	—		$	—		$	125		$	181
Charges	108			6			2			72			188
Cash payments	(27		)	—			—			(82		)	(109		)
Charges against assets	(2		)	(6		)	(2		)	—			(10		)
Foreign exchange	3			—			—			1			4
Balance at June 30, 2017	$	138		$	—		$	—		$	116		$	254

49

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $1 and $2 for the three and six months ended June 30, 2017, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 9, Retirement Plans and Other Retiree Benefits to the Condensed Consolidated Financial Statements).

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three and six months ended June 30, 2017 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $37 and $70, respectively, and contract termination costs and charges resulting directly from exit activities of $1 and $2, respectively. These charges were expensed as incurred.

Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q discusses certain financial measures on both a GAAP and a non-GAAP basis. The Company uses the non-GAAP financial measures described below internally in its budgeting process, to evaluate segment and overall operating performance and as a factor in determining compensation. The Company believes that these non-GAAP financial measures are useful in evaluating the Company’s underlying business performance and trends; however, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

Net sales growth (GAAP) and organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP) are discussed in this Quarterly Report on Form 10-Q. Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments. A reconciliation of organic sales growth to Net sales growth for the three and six months ended June 30, 2017 is provided below.

Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, effective income tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Quarterly Report on Form 10-Q both on a GAAP basis and excluding the charges resulting from the 2012 Restructuring Program and, as applicable, a net benefit related to a previously disclosed foreign tax matter (non-GAAP). These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain divestitures and certain unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three and six months ended June 30, 2017 and 2016 is presented within the applicable section of Results of Operations.

50

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

The following tables provide a quantitative reconciliation of Net sales growth to organic sales growth for the three and six months ended June 30, 2017:

Three Months Ended June 30, 2017	Net Sales Growth (GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact (1)	Organic Sales Growth (Non-GAAP)
Oral, Personal and Home Care
North America	(3.5)%	—%	—%	(3.5)%
Latin America	7.0%	—%	—%	7.0%
Europe	(3.5)%	(3.0)%	—%	(0.5)%
Asia Pacific	(5.0)%	(1.5)%	—%	(3.5)%
Africa/Eurasia	1.0%	4.0%	—%	(3.0)%
Total Oral, Personal and Home Care	(0.5)%	(0.5)%	—%	—%
Pet Nutrition	—%	(0.5)%	—%	0.5%
Total Company	(0.5)%	(0.5)%	—%	—%

Six Months Ended June 30, 2017	Net Sales Growth (GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact (1)	Organic Sales Growth (Non-GAAP)
Oral, Personal and Home Care
North America	(4.5)%	—%	—%	(4.5)%
Latin America	8.0%	1.0%	—%	7.0%
Europe	(4.5)%	(4.0)%	—%	(0.5)%
Asia Pacific	(4.0)%	(1.5)%	—%	(2.5)%
Africa/Eurasia	3.5%	4.5%	—%	(1.0)%
Total Oral, Personal and Home Care	(0.5)%	(0.5)%	—%	—%
Pet Nutrition	—%	—%	—%	—%
Total Company	—%	—%	—%	—%

⁽¹⁾ Represents the impact of acquisitions and divestments, as applicable.

51

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, charges resulting from the 2012 Restructuring Program and stock repurchases). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Net cash provided by operations decreased1% to $1,305 in the first six months of 2017, compared with $1,320 in the comparable period of 2016, primarily due to the timing of income tax payments.

The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt). The Company’s working capital improved to (3.9%) as a percentage of Net sales in the first six months of 2017 as compared to (2.6%) in the first six months of 2016, reflecting the Company’s tight focus on working capital.

Implementation of the 2012 Restructuring Program remains on track. The Company continually seeks new projects and ways to advance the implementation of existing projects in order to accelerate savings under the program and, given the challenging market conditions and slowing category growth experienced in the first six months of 2017, it has identified additional opportunities and now estimates savings and charges to be at the upper end of its previously disclosed ranges. Total program charges resulting from the 2012 Restructuring Program are now estimated to be $1,500 to $1,585 pretax ($1,120 to $1,170 aftertax) as compared to the previous estimate of $1,405 to $1,585 pretax ($1,050 to $1,170 aftertax). Approximately 75% of total program charges resulting from the 2012 Restructuring Program are expected to result in cash expenditures. Savings from the 2012 Restructuring Program, substantially all of which are expected to increase future cash flows, are now projected to be in the range of $455 to $495 pretax ($425 to $475 aftertax) annually, once all projects are approved and implemented, as compared to the previous estimate of $430 to $495 pretax ($400 to $475 aftertax).

The anticipated pretax charges for 2017 are now expected to approximate $275 to $360 ($210 to $260 aftertax) as compared to the previous estimate of $180 to $360 ($140 to $260 aftertax). Savings in 2017 are now expected to approximate $50 to $60 pretax ($40 to $50 aftertax) as compared to the previous estimate of $40 to $60 pretax ($30 to $50 aftertax). It is anticipated that cash requirements for the 2012 Restructuring Program will be funded from operating cash flows. Approximately 75% of the restructuring accrual at June 30, 2017 is expected to be paid in the next twelve months.

Investing activities used $312 of cash in the first six months of 2017, compared with $340 in the comparable period of 2016. Purchases of marketable securities and investments increased in the first six months of 2017 to $201 from $183 in the comparable period of 2016. Proceeds from the sale of marketable securities and investments also increased in the first six months of 2017 to $114 from $87 in the comparable period of 2016.

Capital spending decreased in the first six months of 2017 to $229 from $248 in the comparable period of 2016. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns. Capital expenditures for 2017 are expected to be approximately 4.0% of Net sales, which remains higher than the Company’s historical rate of approximately 3.5%, primarily due to the 2012 Restructuring Program.

Financing activities used $1,119 of cash during the first six months of 2017, compared with $867 in the comparable period of 2016, reflecting higher purchases of treasury shares and higher net principal payments on debt, partially offset by higher proceeds from the exercise of stock options in the first six months of 2017 compared to the first six months of 2016.

Long-term debt, including the current portion, decreased to $6,506 as of June 30, 2017 as compared to $6,520 as of December 31, 2016 and total debt decreased to $6,519 as of June 30, 2017 as compared to $6,533 as of December 31, 2016. The Company’s debt issuances support its capital structure strategy objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital.

52

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Domestic and foreign commercial paper outstanding was $883 and $0 as of June 30, 2017 and 2016, respectively. Commercial paper outstanding as of June 30, 2017 is U.S. dollar-denominated. Proceeds from the outstanding commercial paper in the second quarter of 2017 were used to repay and retire $250 of U.S. dollar-denominated notes, which became due during the second quarter. Proceeds from the outstanding commercial paper in the first quarter of 2017 were used to repay and retire $400 of U.S. dollar-denominated notes, which became due during the first quarter. The average daily balances outstanding for commercial paper in the first six months of 2017 and 2016 were $1,587 and $1,420, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its line of credit that expires in November 2020.

Certain of the agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

In the first quarter of 2017, the Company increased the annualized common stock dividend by 3% to $1.60 per share, effective in the second quarter of 2017.

Cash and cash equivalents decreased$74 during the first six months of 2017 to $1,241 at June 30, 2017, compared to $1,315 at December 31, 2016, most of which ($1,209 and $1,273, respectively) were held by the Company’s foreign subsidiaries. The Company regularly assesses its cash needs and the available sources to fund these needs and, as part of this assessment, the Company determines the amount of foreign earnings it intends to repatriate to help fund its domestic cash needs and provides applicable U.S. income and foreign withholding taxes on such earnings.

As of December 31, 2016, the Company had approximately $3,400 of undistributed earnings of foreign subsidiaries for which no U.S. income or foreign withholding taxes have been provided as the Company considered such earnings to be indefinitely reinvested outside of the U.S. and, therefore, not subject to such taxes.

In order to fully recognize a $210 U.S. income tax benefit in 2016 principally related to changes in Venezuela’s foreign exchange regime, during the quarter ended March 31, 2016, the Company decided to repatriate in 2016 $1,500 of earnings of foreign subsidiaries it previously considered indefinitely reinvested outside of the U.S., and accordingly, recorded a tax charge of $210 during the first quarter of 2016. The Company currently does not anticipate a need to repatriate additional undistributed earnings of foreign subsidiaries. Any future repatriation would be subject to applicable U.S. income and foreign withholding taxes. As the Company operates in over 200 countries and territories throughout the world, and due to the complexities in the tax laws and the assumptions that would have to be made, it is not practicable to determine the tax liability that would arise if these earnings were repatriated.

For additional information regarding liquidity and capital resources, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

53

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Per Share Amounts)

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Quarterly Report on Form 10-Q are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. We believe that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (“SEC”) in its rules, regulations and releases) that set forth anticipated results based on management’s plans and assumptions. Such statements may relate, for example, to sales or volume growth, organic sales growth, profit or profit margin growth, earnings per share growth, financial goals, the impact of foreign exchange volatility, cost-reduction plans, including the 2012 Restructuring Program, tax rates, the need to repatriate undistributed earnings of foreign subsidiaries, new product introductions, commercial investment levels, acquisitions and divestitures, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain economic environment in different countries and its effect on consumer spending habits, increased competition and evolving competitive practices, foreign currency rate fluctuations, exchange controls, price or profit controls, labor relations, changes in foreign or domestic laws or regulations or their interpretation, political and fiscal developments, including changes in trade, tax and immigration policies, disruptions in global supply chain, the availability and cost of raw and packaging materials, the ability to maintain or increase selling prices as needed, the ability to implement the 2012 Restructuring Program as planned or differences between the actual and the estimated costs or savings under such program, changes in the policies of retail trade customers, the emergence of new sales channels, including e-commerce, the ability to continue lowering costs, the ability to complete acquisitions and divestitures as planned and the uncertainty of the outcome of legal proceedings, whether or not the Company believes they have merit. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 and subsequent Quarterly Reports on Form 10-Q).

Quantitative and Qualitative Disclosures about Market Risk

There is no material change in the information reported under Part II, Item 7, “Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure” contained in our Annual Report on Form 10-K for the year ended December 31, 2016.

54

COLGATE-PALMOLIVE COMPANY

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of June 30, 2017 (the “Evaluation”). Based upon the Evaluation, the Company’s Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. As part of the 2012 Restructuring Program, the Company is implementing a shared business service organization model in all regions of the world. At this time, certain financial transaction processing activities have been transitioned to these shared business services centers. The Company does not expect this transition to materially affect its internal control over financial reporting.

55

COLGATE-PALMOLIVE COMPANY

PART II.OTHER INFORMATION

Item 1.Legal Proceedings

For information regarding legal matters, please refer to Note 11, Contingencies to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

Item 1A.Risk Factors

There have been no material changes from the risk factors disclosed in Part 1, Item 1A. Risk Factors of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

56

COLGATE-PALMOLIVE COMPANY

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

On February 19, 2015, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a share repurchase program (the “2015 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months in the quarter ended June 30, 2017:

Month	Total Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3) (in millions)
April 1 through 30, 2017	495,944	$	73.30	450,000	$	2,060
May 1 through 31, 2017	1,910,058	$	72.81	1,874,473	$	1,924
June 1 through 30, 2017	1,980,108	$	75.94	1,946,000	$	1,776
Total	4,386,110	$	74.28	4,270,473

⁽¹⁾  Includes share repurchases under the 2015 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

⁽²⁾  The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 115,637 shares, which represents shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.

⁽³⁾  Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of June 30, 2017.

Item 3.Defaults Upon Senior Securities

None.

Item 4.Mine Safety Disclosures

Not Applicable.

Item 5.Other Information

None.

57

COLGATE-PALMOLIVE COMPANY

Item 6.Exhibits

Exhibit No.	Description
12	Computation of Ratio of Earnings to Fixed Charges.
31-A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
31-B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
32	Certificate of the Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350.
101	The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2017, formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income; (ii) the Condensed Consolidated Statements of Comprehensive Income; (iii) the Condensed Consolidated Balance Sheets; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) Notes to Condensed Consolidated Financial Statements.

58

COLGATE-PALMOLIVE COMPANY

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	COLGATE-PALMOLIVE COMPANY
	(Registrant)
	Principal Executive Officer:
July 21, 2017	/s/ Ian Cook
	Ian Cook
	Chairman of the Board, President and Chief Executive Officer
	Principal Financial Officer:
July 21, 2017	/s/ Dennis J. Hickey
	Dennis J. Hickey
	Chief Financial Officer
	Principal Accounting Officer:
July 21, 2017	/s/ Victoria L. Dolan
	Victoria L. Dolan
	Chief Transformation Officer and Corporate Controller

59

EX-12

EXHIBIT 12

COLGATE-PALMOLIVE COMPANY

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in Millions)

(Unaudited)

	Six Months Ended June 30, 2017
Earnings:
Income before income taxes	1,691
Add:
Fixed charges	107
Less:
Income from equity investees	(6		)
Capitalized interest	(1		)
Income as adjusted	$	1,791
Fixed Charges:
Interest on indebtedness and amortization of debt expense and discount or premium	$	72
Rents of one-third representative of interest factor	34
Capitalized interest	1
Total fixed charges	$	107
Ratio of earnings to fixed charges	16.7

EX-31.A

EXHIBIT 31-A

I, Ian Cook, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 21, 2017

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

EX-31.B

EXHIBIT 31-B

I, Dennis J. Hickey, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 21, 2017

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

EX-32

EXHIBIT 32

The undersigned Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer of Colgate-Palmolive Company each certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, that:

(1) the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2017 (the “Periodic Report”) which this statement accompanies fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Colgate-Palmolive Company.

Date: July 21, 2017

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

XML

Document and Entity Information	6 Months Ended
	Jun. 30, 2017 shares
Document and Entity Information [Abstract]
Entity Registrant Name	COLGATE PALMOLIVE CO
Entity Central Index Key	0000021665
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q2
Amendment Flag	false
Trading Symbol	CL
Entity Common Stock, Shares Outstanding	880,841,977

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) $ in Millions		3 Months Ended				6 Months Ended
		Jun. 30, 2017 USD ($) $ / shares	Mar. 31, 2017 Dividend	Jun. 30, 2016 USD ($) $ / shares	Mar. 31, 2016 Dividend	Jun. 30, 2017 USD ($) $ / shares	Jun. 30, 2016 USD ($) $ / shares
Income Statement [Abstract]
Net sales		$ 3,826		$ 3,845		$ 7,588	$ 7,607
Cost of sales		1,526		1,541		3,019	3,055
Gross profit		2,300		2,304		4,569	4,552
Selling, general and administrative expenses		1,333		1,320		2,695	2,674
Other (income) expense, net		114		40		136	67
Operating profit		853		944		1,738	1,811
Interest (income) expense, net		24		25		47	53
Income before income taxes		829		919		1,691	1,758
Provision for income taxes		269		281		520	546
Net income including noncontrolling interests		560		638		1,171	1,212
Less: Net income attributable to noncontrolling interests		36		38		77	79
Net income attributable to Colgate-Palmolive Company		$ 524		$ 600		$ 1,094	$ 1,133
Earnings per common share, basic (in dollars per share) | $ / shares		$ 0.59		$ 0.67		$ 1.24	$ 1.27
Earnings per common share, diluted (in dollars per share) | $ / shares		0.59		0.67		1.23	1.26
Dividends declared per common share (in dollars per share) | $ / shares	[1]	$ 0.40		$ 0.39		$ 1.19	$ 1.16
Number of dividends declared per quarter (in dividends) | Dividend			2		2

[1] Two dividends were declared in the first quarter of 2017 and 2016.

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income including noncontrolling interests	$ 560	$ 638	$ 1,171	$ 1,212
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	98	(43)	230	83
Retirement plans and other retiree benefit adjustments	12	12	25	23
Gains (losses) on available-for-sale securities	0	0	0	0
Gains (losses) on cash flow hedges	(3)	7	(13)	(4)
Total Other comprehensive income (loss), net of tax	107	(24)	242	102
Total Comprehensive income including noncontrolling interests	667	614	1,413	1,314
Less: Net income attributable to noncontrolling interests	36	38	77	79
Less: Cumulative translation adjustments attributable to noncontrolling interests	2	(6)	9	(5)
Total Comprehensive income attributable to noncontrolling interests	38	32	86	74
Total Comprehensive income attributable to Colgate-Palmolive Company	$ 629	$ 582	$ 1,327	$ 1,240

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Current Assets
Cash and cash equivalents	$ 1,241	$ 1,315
Receivables (net of allowances of $75 and $73, respectively)	1,526	1,411
Inventories	1,199	1,171
Other current assets	589	441
Total current assets	4,555	4,338
Property, plant and equipment:
Cost	8,261	7,942
Less: Accumulated depreciation	(4,331)	(4,102)
Property, plant and equipment, net	3,930	3,840
Goodwill	2,191	2,107
Other intangible assets, net	1,340	1,313
Deferred income taxes	360	301
Other assets	204	224
Total assets	12,580	12,123
Current Liabilities
Notes and loans payable	13	13
Current portion of long-term debt	0	0
Accounts payable	1,131	1,124
Accrued income taxes	404	441
Other accruals	2,232	1,727
Total current liabilities	3,780	3,305
Long-term debt	6,506	6,520
Deferred income taxes	195	246
Other liabilities	2,011	2,035
Total liabilities	12,492	12,106
Shareholders’ Equity
Common stock	1,466	1,466
Additional paid-in capital	1,854	1,691
Retained earnings	19,952	19,922
Accumulated other comprehensive income (loss)	(3,947)	(4,180)
Unearned compensation	(2)	(7)
Treasury stock, at cost	(19,565)	(19,135)
Total Colgate-Palmolive Company shareholders’ equity	(242)	(243)
Noncontrolling interests	330	260
Total equity	88	17
Total liabilities and equity	$ 12,580	$ 12,123

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 75	$ 73

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Operating Activities
Net income including noncontrolling interests	$ 1,171	$ 1,212
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	226	215
Restructuring and termination benefits, net of cash	78	8
Stock-based compensation expense	53	48
Deferred income taxes	(64)	(41)
Voluntary benefit plan contributions	(57)	(50)
Cash effects of changes in:
Receivables	(64)	(132)
Inventories	9	(35)
Accounts payable and other accruals	(61)	69
Other non-current assets and liabilities	14	26
Net cash provided by operations	1,305	1,320
Investing Activities
Capital expenditures	(229)	(248)
Purchases of marketable securities and investments	(201)	(183)
Proceeds from sale of marketable securities and investments	114	87
Other	4	4
Net cash used in investing activities	(312)	(340)
Financing Activities
Principal payments on debt	(1,841)	(4,078)
Proceeds from issuance of debt	1,761	4,123
Dividends paid	(716)	(704)
Purchases of treasury shares	(660)	(482)
Proceeds from exercise of stock options	337	274
Net cash used in financing activities	(1,119)	(867)
Effect of exchange rate changes on Cash and cash equivalents	52	2
Net increase (decrease) in Cash and cash equivalents	(74)	115
Cash and cash equivalents at beginning of the period	1,315	970
Cash and cash equivalents at end of the period	1,241	1,085
Supplemental Cash Flow Information
Income taxes paid	$ 639	$ 507

XML

Basis of Presentation

6 Months Ended

Jun. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. The Company reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.

For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, filed with the Securities and Exchange Commission.

XML

Use of Estimates

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

XML

Recent Accounting Pronouncements

6 Months Ended

Jun. 30, 2017

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

On May 10, 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09, “Compensation–Stock Compensation (Topic 718): Scope of Modification Accounting,” clarifying when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance is effective for the Company on a prospective basis beginning on January 1, 2018, with early adoption permitted. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements as it is not the Company’s practice to change either the terms or conditions of share-based payment awards once they are granted.

On March 10, 2017, the FASB issued ASU No. 2017-07, “Compensation–Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,” changing the presentation of the net periodic benefit cost on the Statement of Income and limiting the amount of net periodic benefit cost eligible for capitalization to assets. The new guidance permits only the service cost component of net periodic benefit cost to be eligible for capitalization. The new guidance also requires entities to present the service cost component of net periodic benefit cost together with compensation costs arising from services rendered by employees during the period. Other components of net periodic benefit cost, which include interest, expected return on assets, amortization of prior service costs and actuarial gains and losses, are required to be presented outside of Operating profit. The line item or items used to present the other components of net periodic benefit cost must be disclosed in the Notes to the Consolidated Financial Statements, if not separately described on the Statement of Income. The new presentation requirement is required to be adopted on a “full retrospective” basis, meaning the standard is applied to all of the periods presented in the financial statements, while the limitation on capitalization can only be adopted on a prospective basis. The new guidance is effective for the Company beginning on January 1, 2018, with early adoption permitted. While the Company is currently assessing the impact of the new standard on its Consolidated Financial Statements, based on its historical results, it anticipates that, as a result of the reclassification, full year Operating profit will increase by approximately $100 annually with no impact on Net income attributable to Colgate-Palmolive Company.

On January 26, 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On January 5, 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business,” which provides additional guidance on evaluating whether transactions should be accounted for as acquisitions of assets or businesses. The guidance requires an entity to evaluate if substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the new guidance would define this as an asset acquisition; otherwise, the entity then evaluates whether the asset meets the requirement that a business include, at a minimum, an input and substantive process that together significantly contribute to the ability to create outputs. The guidance is effective for the Company on a prospective basis beginning on January 1, 2018, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On October 24, 2016, the FASB issued ASU No. 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity asset transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. As permitted, the Company early-adopted the new standard on a “modified retrospective” basis, meaning the standard is applied only to the most recent period presented in the financial statements, as of January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

On August 26, 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” which clarifies how certain cash receipts and payments are to be presented in the statement of cash flows. The guidance is effective for the Company beginning on January 1, 2018, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On March 30, 2016, the FASB issued ASU No. 2016-09, “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amended accounting for income taxes related to share-based compensation, the related classification in the statement of cash flows and share award forfeiture accounting. The new guidance was effective for the Company beginning on January 1, 2017. As required subsequent to the adoption of this new guidance, the Company recognized excess tax benefits of $8 and $26 (resulting from an increase in the fair value of an award from grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the three and six months ended June 30, 2017, respectively. These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits were recognized in equity. As permitted, the Company elected to classify excess tax benefits as an operating activity in the Statement of Cash Flows instead of as a financing activity on a prospective basis and did not retrospectively adjust prior periods. Also, as permitted by the new standard, the Company elected to account for forfeitures as they occur.

On March 15, 2016, the FASB issued ASU No. 2016-07, “Investments–Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting,” which eliminated the requirement to retroactively adjust an investment that subsequently qualifies for equity method accounting (as a result of an increase in level of ownership interest or degree of influence) as if the equity method of accounting had been applied during all prior periods that the investment was held. The new standard requires that the investor add the cost of acquiring additional ownership interest in the investee to its current basis and prospectively apply the equity method of accounting. For an available-for-sale investment, any unrealized gains or losses should be recognized in earnings at the date the investment qualifies as an equity method investment. The new guidance was effective for the Company beginning on January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

On February 25, 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which supersedes Topic 840, “Leases.” The new accounting standard requires the recognition of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The new standard also provides additional guidance on the measurement of the right-of-use assets and lease liabilities and will require enhanced disclosures about the Company’s leasing arrangements. Under current accounting standards, substantially all of the Company’s leases are considered operating leases and, as such, are not recognized on the Consolidated Balance Sheet. This new standard is effective for the Company beginning on January 1, 2019, with early adoption permitted. The standard requires a “modified retrospective” adoption, meaning the standard is applied to leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The Company is currently assessing the impact of the new standard on its Consolidated Financial Statements.

On January 5, 2016, the FASB issued ASU No. 2016-01, “Financial Instruments–Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The updated guidance enhances the reporting model for financial instruments which includes amendments to address aspects of recognition, measurement, presentation and disclosure. The amendment to the standard is effective for the Company beginning on January 1, 2018. While the Company is currently assessing the impact of the new standard, it does not expect this new guidance to have a material impact on its Consolidated Financial Statements.

On July 22, 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory,” which simplifies the subsequent measurement of inventories by replacing the lower of cost or market test with a lower of cost and net realizable value test. The guidance applies only to inventories for which cost is determined by methods other than last-in first-out (“LIFO”) and the retail inventory method. The new guidance was effective for the Company beginning on January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

On May 28, 2014, the FASB and the International Accounting Standards Board issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” by the FASB, provides a comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to its customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures. During 2016, the FASB issued several accounting updates (ASU No. 2016-08, 2016-10 and 2016-12) to clarify implementation guidance and correct unintended application of the guidance. The standard allows for either full retrospective adoption or modified retrospective adoption. The Company plans to adopt the new standard on January 1, 2018, on a “modified retrospective” basis. The Company continues to make progress in its assessment and implementation of the new standard and while the completion of this assessment is still ongoing, based on the progress to date, the Company does not expect the new standard will have a material impact on its revenue recognition accounting policy or its Consolidated Financial Statements.

XML

Restructuring and Related Implementation Charges

6 Months Ended

Jun. 30, 2017

Restructuring and Related Activities [Abstract]

Restructuring and Related Implementation Charges

Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a Global Growth and Efficiency Program (as expanded in 2014 and 2015 as described below, the “2012 Restructuring Program”) for sustained growth. The program’s initiatives are expected to help Colgate ensure sustained solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

On October 23, 2014, the Company’s Board of Directors (the “Board”) approved an expansion of the 2012 Restructuring Program to take advantage of additional savings opportunities.

On October 29, 2015, the Board approved the reinvestment of the funds from the sale of the Company’s laundry detergent business in the South Pacific to expand the 2012 Restructuring Program and extend it for one year through December 31, 2017. The Board approved the implementation plan for this expansion on March 10, 2016. Initiatives under the 2012 Restructuring Program continue to fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities.

The Company continually seeks new projects and ways to advance the implementation of existing projects in order to accelerate savings under the program and, given the challenging market conditions and slowing category growth experienced in the first six months of 2017, it has identified additional opportunities and now estimates charges to be at the upper end of its previously disclosed range. Cumulative pretax charges resulting from the 2012 Restructuring Program, once all phases are approved and implemented, are now estimated to be $1,500 to $1,585 ($1,120 to $1,170 aftertax) as compared to the previous estimate of $1,405 to $1,585 ($1,050 to $1,170 aftertax).

The pretax charges resulting from the 2012 Restructuring Program are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (45%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of related implementation charges resulting directly from exit activities (20%) and the implementation of new strategies (25%). Over the course of the 2012 Restructuring Program, it is currently estimated that approximately 75% of the charges will result in cash expenditures. Anticipated pretax charges for 2017 are now expected to approximate $275 to $360 ($210 to $260 aftertax) as compared to the previous estimate of $180 to $360 ($140 to $260 aftertax). It is expected that substantially all charges resulting from the 2012 Restructuring Program will be incurred by December 31, 2017.

It is currently expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe (25%), Latin America (5%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (5%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that, when it has been fully implemented, the 2012 Restructuring Program will contribute a net reduction of approximately 3,300 to 3,800 positions from the Company’s global employee workforce.

For the three and six months ended June 30, 2017 and 2016, restructuring and related implementation charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Cost of sales	$	21	$	12	$	35	$	20
Selling, general and administrative expenses	17		14		38		40
Other (income) expense, net	104		33		115		54
Total 2012 Restructuring Program charges, pretax	$	142	$	59	$	188	$	114
Total 2012 Restructuring Program charges, aftertax	$	115	$	44	$	146	$	82

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:

	Three Months Ended				Six Months Ended				Program-to-date
	June 30,				June 30,				Accumulated Charges
	2017		2016		2017		2016
North America	17	%	23	%	22	%	32	%	17	%
Latin America	3	%	6	%	3	%	7	%	4	%
Europe	55	%	6	%	42	%	7	%	24	%
Asia Pacific	3	%	9	%	3	%	6	%	3	%
Africa/Eurasia	2	%	22	%	2	%	15	%	6	%
Hill’s Pet Nutrition	2	%	17	%	4	%	9	%	7	%
Corporate	18	%	17	%	24	%	24	%	39	%

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,416 ($1,053 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of June 30, 2017
Employee-Related Costs	$	573
Incremental Depreciation	86
Asset Impairments	29
Other	728
Total	$	1,416

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the extension of shared business services and streamlining of global functions; the consolidation of facilities; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; and restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan.

The following tables summarize the activity for the restructuring and related implementation charges discussed above and the related accruals:

	Three Months Ended June 30, 2017
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at March 31, 2017	$	44		$	—		$	—	$	123		$	167
Charges	100			4			—		38			142
Cash payments	(8		)	—			—		(46		)	(54		)
Charges against assets	(1		)	(4		)	—		—			(5		)
Foreign exchange	3			—			—		1			4
Balance at June 30, 2017	$	138		$	—		$	—	$	116		$	254

	Six Months Ended June 30, 2017
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2016	$	56		$	—		$	—		$	125		$	181
Charges	108			6			2			72			188
Cash payments	(27		)	—			—			(82		)	(109		)
Charges against assets	(2		)	(6		)	(2		)	—			(10		)
Foreign exchange	3			—			—			1			4
Balance at June 30, 2017	$	138		$	—		$	—		$	116		$	254

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements.

Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $1 and $2 for the three and six months ended June 30, 2017, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 9, Retirement Plans and Other Retiree Benefits).

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three and six months ended June 30, 2017 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $37 and $70, respectively, and contract termination costs and charges resulting directly from exit activities of $1 and $2, respectively. These charges were expensed as incurred.

XML

Inventories

6 Months Ended

Jun. 30, 2017

Inventory, Net, Items Net of Reserve Alternative [Abstract]

Inventories

Inventories

Inventories by major class are as follows:

	June 30, 2017		December 31, 2016
Raw materials and supplies	$	241	$	266
Work-in-process	47		42
Finished goods	911		863
Total Inventories	$	1,199	$	1,171

XML

Shareholders' Equity

6 Months Ended

Jun. 30, 2017

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the six months endedJune 30, 2017 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2016	$	1,466	$	1,691		$	(7	)	$	(19,135	)	$	19,922		$	(4,180	)	$	260
Net income												1,094						77
Other comprehensive income (loss), net of tax															233			9
Dividends												(1,053		)				(16		)
Stock-based compensation expense			53
Shares issued for stock options			126						208
Shares issued for restricted stock units			(17		)				17
Treasury stock acquired									(660		)
Other			1			5			5			(11		)
Balance, June 30, 2017	$	1,466	$	1,854		$	(2	)	$	(19,565	)	$	19,952		$	(3,947	)	$	330

Accumulated other comprehensive income (loss) includes cumulative translation losses of $2,991 and $3,212 at June 30, 2017 and December 31, 2016, respectively, and unrecognized retirement plan and other retiree benefits costs of $952 and $977 at June 30, 2017 and December 31, 2016, respectively.

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2017

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

	Three Months Ended
	June 30, 2017					June 30, 2016
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	524	883.8	$	0.59	$	600	893.9	$	0.67
Stock options and restricted stock units			7.0					7.2
Diluted EPS	$	524	890.8	$	0.59	$	600	901.1	$	0.67

For the three months endedJune 30, 2017 and 2016, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 5,299,933 and 598,857, respectively.

	Six Months Ended
	June 30, 2017					June 30, 2016
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	1,094	884.2	$	1.24	$	1,133	893.8	$	1.27
Stock options and restricted stock units			6.7					6.9
Diluted EPS	$	1,094	890.9	$	1.23	$	1,133	900.7	$	1.26

For the six months endedJune 30, 2017 and 2016, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 9,051,702 and 356,541, respectively.

Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.

XML

Other Comprehensive Income (Loss)

6 Months Ended

Jun. 30, 2017

Equity [Abstract]

Other Comprehensive Income (Loss)

Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedJune 30, 2017 and 2016 were as follows:

	2017						2016
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	57		$	96		$	(8	)	$	(37	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	—			—			—			—
Amortization of net actuarial loss, transition and prior service costs (1)	19			12			16			12
Retirement plans and other retiree benefits adjustments	19			12			16			12
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	—			—			—			—
Reclassification of (gains) losses into net earnings on available-for-sale securities	—			—			—			—
Gains (losses) on available-for-sale securities	—			—			—			—
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(7		)	(4		)	7			6
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	1			1			2			1
Gains (losses) on cash flow hedges	(6		)	(3		)	9			7
Total Other comprehensive income (loss)	$	70		$	105		$	17		$	(18	)

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the six months endedJune 30, 2017 and 2016 were as follows:

	2017						2016
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	160		$	221		$	86		$	88
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	—			—			—			—
Amortization of net actuarial loss, transition and prior service costs (1)	37			25			32			23
Retirement plans and other retiree benefits adjustments	37			25			32			23
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	—			—			—			—
Reclassification of (gains) losses into net earnings on available-for-sale securities	—			—			—			—
Gains (losses) on available-for-sale securities	—			—			—			—
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(20		)	(12		)	(7		)	(4		)
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(2		)	(1		)	—			—
Gains (losses) on cash flow hedges	(22		)	(13		)	(7		)	(4		)
Total Other comprehensive income (loss)	$	175		$	233		$	111		$	107

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

XML

Retirement Plans and Other Retiree Benefits

6 Months Ended

Jun. 30, 2017

Compensation and Retirement Disclosure [Abstract]

Retirement Plans and Other Retiree Benefits

Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three and six months ended June 30, 2017 and 2016 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended June 30,
	2017			2016			2017			2016			2017		2016
Service cost	$	1		$	1		$	3		$	4		$	4	$	3
Interest cost	23			26			5			6			10		11
ESOP offset	—			—			—			—			—		(1		)
Expected return on plan assets	(28		)	(28		)	(5		)	(6		)	—		—
Amortization of transition and prior service costs (credits)	—			—			—			—			—		—
Amortization of actuarial loss (gain)	12			10			3			2			4		4
Net periodic benefit cost	$	8		$	9		$	6		$	6		$	18	$	17

	Pension Benefits												Other Retiree Benefits
	United States						International
	Six Months Ended June 30,
	2017			2016			2017			2016			2017		2016
Service cost	$	1		$	1		$	7		$	8		$	8	$	6
Interest cost	47			53			10			12			21		22
ESOP offset	—			—			—			—			—		(1		)
Expected return on plan assets	(55		)	(55		)	(10		)	(11		)	—		—
Amortization of transition and prior service costs (credits)	—			—			—			—			—		—
Amortization of actuarial loss (gain)	24			20			5			4			8		8
Net periodic benefit cost	$	17		$	19		$	12		$	13		$	37	$	35

For the six months endedJune 30, 2017, the Company made voluntary contributions of $57 to its U.S. postretirement plans. For the six months endedJune 30, 2016, the Company made voluntary contributions of $50 to its U.S. postretirement plans.

XML

Income Taxes

6 Months Ended

Jun. 30, 2017

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

On March 30, 2016, the FASB issued ASU No. 2016-09, “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amended accounting for income taxes related to share-based compensation. As a result of adopting the standard effective January 1, 2017, the Company recognized excess tax benefits of $8 and $26 (resulting from an increase in the fair value of an award from the grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the three and six months ended June 30, 2017, respectively. These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits were recognized in equity. See Note 3, Recent Accounting Pronouncements for additional information.

Since 2002, the Company has taken a tax position in a foreign jurisdiction that has been challenged by the local tax authorities. In May 2015, the Company became aware of several rulings by the Supreme Court in this foreign jurisdiction disallowing certain tax deductions which had the effect of reversing prior decisions. The Company had taken deductions in prior years similar to those disallowed by such court and as a result, as required, reassessed its tax position and increased its unrecognized tax benefits in 2015.

During the quarter ended June 30, 2016, the Supreme Court in this foreign jurisdiction decided the matter in the Company’s favor for the years 2002 through 2005 and, as a result, the Company recorded a net tax benefit of $13, including interest. The Administrative Court in this jurisdiction has also decided the matter in the Company’s favor for the years 2008 through 2011 by acknowledging the Supreme Court’s ruling for the years 2002 through 2005, which eliminated the possibility for future appeals. The tax benefit of deductions related to this tax position taken for the years 2006 through 2007 and 2012 through 2014 totals approximately $15 at current exchange rates. These deductions are currently being challenged by the tax authorities either in the lower courts or at the administrative level and, if resolved in the Company’s favor, will result in the Company recording additional tax benefits, including interest.

XML

Contingencies

6 Months Ended

Jun. 30, 2017

Loss Contingency [Abstract]

Contingencies

Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, privacy, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $225 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $162. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. Appeals are currently pending at the administrative level. In the event the Company is ultimately unsuccessful in its administrative appeals, further appeals are available within the Brazilian federal courts.

In September 2015, the Company lost one of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a similar action in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.

In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $71, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal and the Company has filed a lawsuit in Brazilian federal court. In the event the Company is unsuccessful in this filing, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

Competition Matters

Certain of the Company’s subsidiaries have been subject to investigations, and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also have involved other consumer goods companies and/or retail customers. These investigations often continue for several years and can result in substantial fines for violations that are found as well as associated private actions for damages. While the Company cannot predict the final financial impact of pending competition law matters, as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The current status of pending competition law matters as of June 30, 2017 (except as noted below) is set forth below.

▪ In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”), pursuant to a Business and Share Sale and Purchase Agreement (the “Sale and Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is entitled to indemnification for this fine from Unilever as provided in the Sale and Purchase Agreement. The fines were confirmed by the Court of Appeal in October 2016. The Company is appealing the decision of the Court of Appeal on behalf of the Company and Sara Lee in the French Supreme Court.

▪ In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11 (based on current exchange rates), which approximates reserves previously taken by the Company for this matter. The Company is currently reviewing the decision, and will likely appeal to the Greek courts.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of June 30, 2017, there were 174 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 146 cases as of March 31, 2017 and 115 cases as of December 31, 2016. During the three months endedJune 30, 2017, 36 new cases were filed and eight cases were resolved by voluntary dismissal or settlement. During the six months ended June 30, 2017, 77 new cases were filed and 18 cases were resolved by voluntary dismissal or settlement. The value of settlements in the quarter and the year-to-date period presented was not material, either individually or in the aggregate, to each such period’s results of operations.

A number of the pending cases are expected to go to trial in 2017. The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary and excess insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. Since the amount of any potential losses from these cases currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.

N8

The Company was a defendant in a lawsuit that was brought in Utah federal court by N8 Medical, Inc. (“N8 Medical”), Brigham Young University (“BYU”) and N8 Pharmaceuticals, Inc. (“N8 Pharma”). The complaint, originally filed in November 2013, alleged breach of contract and other torts arising out of the Company’s evaluation of a technology owned by BYU and licensed, at various times, to Ceragenix Pharmaceuticals, Inc., now in bankruptcy, N8 Medical and N8 Pharma.

In 2016, the Company resolved the claims brought by BYU and N8 Medical. These claims were each resolved in an amount that is not material to the Company’s results of operations. In the first quarter of 2017, the court dismissed the claims of N8 Pharma, which has filed a Notice of Appeal.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals (the “Company Defendants”) in the United States District Court for the Southern District of New York. The Company Defendants filed a motion to dismiss this action, which was denied in February 2017. This action has not yet been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest, and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.

XML

Segment Information

6 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Segment Information

Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016
Net sales
Oral, Personal and Home Care
North America	$	764		$	793		$	1,524		$	1,593
Latin America	1,002			938			1,926			1,786
Europe	584			606			1,142			1,194
Asia Pacific	663			697			1,383			1,440
Africa/Eurasia	241			239			487			470
Total Oral, Personal and Home Care	3,254			3,273			6,462			6,483
Pet Nutrition	572			572			1,126			1,124
Total Net sales	$	3,826		$	3,845		$	7,588		$	7,607
Operating profit
Oral, Personal and Home Care
North America	$	241		$	250		$	474		$	489
Latin America	308			284			577			531
Europe	145			138			285			279
Asia Pacific	205			219			424			438
Africa/Eurasia	45			45			90			88
Total Oral, Personal and Home Care	944			936			1,850			1,825
Pet Nutrition	163			162			320			317
Corporate	(254		)	(154		)	(432		)	(331		)
Total Operating profit	$	853		$	944		$	1,738		$	1,811

Approximately 75% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

For the three months endedJune 30, 2017, Corporate Operating profit (loss) included charges of $142 resulting from the 2012 Restructuring Program. For the six months endedJune 30, 2017, Corporate Operating profit (loss) included charges of $188 resulting from the 2012 Restructuring Program.

For the three months endedJune 30, 2016, Corporate Operating profit (loss) included charges of $59 resulting from the 2012 Restructuring Program. For the six months endedJune 30, 2016, Corporate Operating profit (loss) included charges of $114 resulting from the 2012 Restructuring Program.

For further information regarding the 2012 Restructuring Program, refer to Note 4, Restructuring and Related Implementation Charges.

XML

Fair Value Measurements and Financial Instruments

6 Months Ended

Jun. 30, 2017

Financial Instruments and Fair Value Measurements [Abstract]

Fair Value Measurements and Financial Instruments

Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at June 30, 2017 and December 31, 2016:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		6/30/17		12/31/16			6/30/17		12/31/16
Interest rate swap contracts	Other current assets	$	—	$	1	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	—		1		Other liabilities	1		—
Foreign currency contracts	Other current assets	13		29		Other accruals	28		4
Foreign currency contracts	Other assets	—		5		Other liabilities	26		—
Commodity contracts	Other current assets	—		—		Other accruals	—		—
Total designated		$	13	$	36		$	55	$	4
Derivatives not designated
Foreign currency contracts	Other current assets	$	—	$	—	Other accruals	$	1	$	—
Total not designated		$	—	$	—		$	1	$	—
Total derivative instruments		$	13	$	36		$	56	$	4
Other financial instruments
Marketable securities	Other current assets	$	144	$	23
Total other financial instruments		$	144	$	23

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of June 30, 2017 and December 31, 2016. The estimated fair value of the Company’s long-term debt, including the current portion, as of June 30, 2017 and December 31, 2016, was $6,710 and $6,717, respectively, and the related carrying value was $6,506 and $6,520, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

Fair Value Hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting gain or loss on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net.

Activity related to fair value hedges recorded during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017									2016
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at June 30,	$	930		$	600		$	1,530		$	347		$	1,250		$	1,597
Three months ended June 30,
Gain (loss) on derivatives	(3		)	—			(3		)	(6		)	1			(5		)
Gain (loss) on hedged items	3			—			3			6			(1		)	5
Six months ended June 30,
Gain (loss) on derivatives	(1		)	(2		)	(3		)	(5		)	9			4
Gain (loss) on hedged items	1			2			3			5			(9		)	(4		)

Cash Flow Hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017								2016
	Foreign Currency Contracts			Commodity Contracts		Total			Foreign Currency Contracts			Commodity Contracts		Total
Notional Value at June 30,	$	719		$	2	$	721		$	705		$	9	$	714
Three months ended June 30,
Gain (loss) recognized in OCI	(7		)	—		(7		)	5			2		7
Gain (loss) reclassified into Cost of sales	(1		)	—		(1		)	(3		)	1		(2		)
Six months ended June 30,
Gain (loss) recognized in OCI	(20		)	—		(20		)	(9		)	2		(7		)
Gain (loss) reclassified into Cost of sales	2			—		2			—			—		—

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is generally expected to be recognized in Cost of sales within the next twelve months.

Net Investment Hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Cumulative translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

Activity related to net investment hedges recorded during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017									2016
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at June 30,	$	800		$	572		$	1,372		$	895		$	1,280		$	2,175
Three months ended June 30,
Gain (loss) on instruments	(28		)	(78		)	(106		)	10			26			36
Gain (loss) on hedged items	27			78			105			(7		)	(26		)	(33		)
Six months ended June 30,
Gain (loss) on instruments	(46		)	(93		)	(139		)	(16		)	(23		)	(39		)
Gain (loss) on hedged items	47			93			140			16			23			39

Derivatives not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for the second quarter of 2017 include foreign currency contracts for which the gain or loss on the instrument is recognized in Other (income) expense, net for the three and six months ended June 30, 2017. During the second quarter of 2017, the Company de-designated foreign currency forward contracts previously designated as net investment hedges and entered into new derivative instruments with offsetting terms. Gains or losses on these de-designated derivatives were substantially offset by gains and losses on the new derivative instruments.

Derivatives not designated as hedging instruments for the second quarter of 2016 consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period.

Activity related to these contracts during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017		2016
	Foreign Currency Contracts		Foreign Currency Contracts
Notional Value at June 30,	$	48	$	5
Three months ended June 30,
Gain (loss) on instruments	—		2
Gain (loss) on hedged items	—		(2		)
Six months ended June 30,
Gain (loss) on instruments	—		5
Gain (loss) on hedged items	—		(5		)

Other Financial Instruments

Other financial instruments are classified as Other current assets or Other assets.

Other financial instruments classified as Other current assets include marketable securities consisting of bank deposits of $144 with original maturities greater than 90 days carried at fair value (Level 1 valuation) and the current portion of bonds issued by the Argentinian government in the amount of $11 classified as held-to-maturity and carried at amortized cost.

Through its subsidiary in Argentina, the Company has invested in U.S. dollar-linked, devaluation-protected bonds issued by the Argentinian government. As of June 30, 2017, the amortized cost was $11 and their approximate fair value was $11 (Level 2 valuation).

XML

Use of Estimates (Policies)

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

On May 10, 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09, “Compensation–Stock Compensation (Topic 718): Scope of Modification Accounting,” clarifying when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance is effective for the Company on a prospective basis beginning on January 1, 2018, with early adoption permitted. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements as it is not the Company’s practice to change either the terms or conditions of share-based payment awards once they are granted.

On March 10, 2017, the FASB issued ASU No. 2017-07, “Compensation–Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,” changing the presentation of the net periodic benefit cost on the Statement of Income and limiting the amount of net periodic benefit cost eligible for capitalization to assets. The new guidance permits only the service cost component of net periodic benefit cost to be eligible for capitalization. The new guidance also requires entities to present the service cost component of net periodic benefit cost together with compensation costs arising from services rendered by employees during the period. Other components of net periodic benefit cost, which include interest, expected return on assets, amortization of prior service costs and actuarial gains and losses, are required to be presented outside of Operating profit. The line item or items used to present the other components of net periodic benefit cost must be disclosed in the Notes to the Consolidated Financial Statements, if not separately described on the Statement of Income. The new presentation requirement is required to be adopted on a “full retrospective” basis, meaning the standard is applied to all of the periods presented in the financial statements, while the limitation on capitalization can only be adopted on a prospective basis. The new guidance is effective for the Company beginning on January 1, 2018, with early adoption permitted. While the Company is currently assessing the impact of the new standard on its Consolidated Financial Statements, based on its historical results, it anticipates that, as a result of the reclassification, full year Operating profit will increase by approximately $100 annually with no impact on Net income attributable to Colgate-Palmolive Company.

On January 26, 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On January 5, 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business,” which provides additional guidance on evaluating whether transactions should be accounted for as acquisitions of assets or businesses. The guidance requires an entity to evaluate if substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the new guidance would define this as an asset acquisition; otherwise, the entity then evaluates whether the asset meets the requirement that a business include, at a minimum, an input and substantive process that together significantly contribute to the ability to create outputs. The guidance is effective for the Company on a prospective basis beginning on January 1, 2018, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On October 24, 2016, the FASB issued ASU No. 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity asset transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. As permitted, the Company early-adopted the new standard on a “modified retrospective” basis, meaning the standard is applied only to the most recent period presented in the financial statements, as of January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

On August 26, 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” which clarifies how certain cash receipts and payments are to be presented in the statement of cash flows. The guidance is effective for the Company beginning on January 1, 2018, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

On March 30, 2016, the FASB issued ASU No. 2016-09, “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amended accounting for income taxes related to share-based compensation, the related classification in the statement of cash flows and share award forfeiture accounting. The new guidance was effective for the Company beginning on January 1, 2017. As required subsequent to the adoption of this new guidance, the Company recognized excess tax benefits of $8 and $26 (resulting from an increase in the fair value of an award from grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the three and six months ended June 30, 2017, respectively. These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits were recognized in equity. As permitted, the Company elected to classify excess tax benefits as an operating activity in the Statement of Cash Flows instead of as a financing activity on a prospective basis and did not retrospectively adjust prior periods. Also, as permitted by the new standard, the Company elected to account for forfeitures as they occur.

On March 15, 2016, the FASB issued ASU No. 2016-07, “Investments–Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting,” which eliminated the requirement to retroactively adjust an investment that subsequently qualifies for equity method accounting (as a result of an increase in level of ownership interest or degree of influence) as if the equity method of accounting had been applied during all prior periods that the investment was held. The new standard requires that the investor add the cost of acquiring additional ownership interest in the investee to its current basis and prospectively apply the equity method of accounting. For an available-for-sale investment, any unrealized gains or losses should be recognized in earnings at the date the investment qualifies as an equity method investment. The new guidance was effective for the Company beginning on January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

On February 25, 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which supersedes Topic 840, “Leases.” The new accounting standard requires the recognition of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The new standard also provides additional guidance on the measurement of the right-of-use assets and lease liabilities and will require enhanced disclosures about the Company’s leasing arrangements. Under current accounting standards, substantially all of the Company’s leases are considered operating leases and, as such, are not recognized on the Consolidated Balance Sheet. This new standard is effective for the Company beginning on January 1, 2019, with early adoption permitted. The standard requires a “modified retrospective” adoption, meaning the standard is applied to leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The Company is currently assessing the impact of the new standard on its Consolidated Financial Statements.

On January 5, 2016, the FASB issued ASU No. 2016-01, “Financial Instruments–Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The updated guidance enhances the reporting model for financial instruments which includes amendments to address aspects of recognition, measurement, presentation and disclosure. The amendment to the standard is effective for the Company beginning on January 1, 2018. While the Company is currently assessing the impact of the new standard, it does not expect this new guidance to have a material impact on its Consolidated Financial Statements.

On July 22, 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory,” which simplifies the subsequent measurement of inventories by replacing the lower of cost or market test with a lower of cost and net realizable value test. The guidance applies only to inventories for which cost is determined by methods other than last-in first-out (“LIFO”) and the retail inventory method. The new guidance was effective for the Company beginning on January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

On May 28, 2014, the FASB and the International Accounting Standards Board issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” by the FASB, provides a comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to its customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures. During 2016, the FASB issued several accounting updates (ASU No. 2016-08, 2016-10 and 2016-12) to clarify implementation guidance and correct unintended application of the guidance. The standard allows for either full retrospective adoption or modified retrospective adoption. The Company plans to adopt the new standard on January 1, 2018, on a “modified retrospective” basis. The Company continues to make progress in its assessment and implementation of the new standard and while the completion of this assessment is still ongoing, based on the progress to date, the Company does not expect the new standard will have a material impact on its revenue recognition accounting policy or its Consolidated Financial Statements.

XML

Restructuring and Related Implementation Charges (Tables)

6 Months Ended

Jun. 30, 2017

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

For the three and six months ended June 30, 2017 and 2016, restructuring and related implementation charges are reflected in the Condensed Consolidated Statements of Income as follows:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Cost of sales	$	21	$	12	$	35	$	20
Selling, general and administrative expenses	17		14		38		40
Other (income) expense, net	104		33		115		54
Total 2012 Restructuring Program charges, pretax	$	142	$	59	$	188	$	114
Total 2012 Restructuring Program charges, aftertax	$	115	$	44	$	146	$	82

Schedule of Percent of Total Restructuring Charges Related To Segment for the period

Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:

	Three Months Ended				Six Months Ended				Program-to-date
	June 30,				June 30,				Accumulated Charges
	2017		2016		2017		2016
North America	17	%	23	%	22	%	32	%	17	%
Latin America	3	%	6	%	3	%	7	%	4	%
Europe	55	%	6	%	42	%	7	%	24	%
Asia Pacific	3	%	9	%	3	%	6	%	3	%
Africa/Eurasia	2	%	22	%	2	%	15	%	6	%
Hill’s Pet Nutrition	2	%	17	%	4	%	9	%	7	%
Corporate	18	%	17	%	24	%	24	%	39	%

Schedule of Restructuring and Related Costs Incurred to Date

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,416 ($1,053 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of June 30, 2017
Employee-Related Costs	$	573
Incremental Depreciation	86
Asset Impairments	29
Other	728
Total	$	1,416

Schedule of Restructuring Reserve by Type of Cost

The following tables summarize the activity for the restructuring and related implementation charges discussed above and the related accruals:

	Three Months Ended June 30, 2017
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at March 31, 2017	$	44		$	—		$	—	$	123		$	167
Charges	100			4			—		38			142
Cash payments	(8		)	—			—		(46		)	(54		)
Charges against assets	(1		)	(4		)	—		—			(5		)
Foreign exchange	3			—			—		1			4
Balance at June 30, 2017	$	138		$	—		$	—	$	116		$	254

	Six Months Ended June 30, 2017
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2016	$	56		$	—		$	—		$	125		$	181
Charges	108			6			2			72			188
Cash payments	(27		)	—			—			(82		)	(109		)
Charges against assets	(2		)	(6		)	(2		)	—			(10		)
Foreign exchange	3			—			—			1			4
Balance at June 30, 2017	$	138		$	—		$	—		$	116		$	254

XML

Inventories (Tables)

6 Months Ended

Jun. 30, 2017

Inventory, Net, Items Net of Reserve Alternative [Abstract]

Inventories By Major Class

Inventories by major class are as follows:

	June 30, 2017		December 31, 2016
Raw materials and supplies	$	241	$	266
Work-in-process	47		42
Finished goods	911		863
Total Inventories	$	1,199	$	1,171

XML

Shareholders' Equity (Tables)

6 Months Ended

Jun. 30, 2017

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Changes in the components of Shareholders’ Equity for the six months endedJune 30, 2017 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2016	$	1,466	$	1,691		$	(7	)	$	(19,135	)	$	19,922		$	(4,180	)	$	260
Net income												1,094						77
Other comprehensive income (loss), net of tax															233			9
Dividends												(1,053		)				(16		)
Stock-based compensation expense			53
Shares issued for stock options			126						208
Shares issued for restricted stock units			(17		)				17
Treasury stock acquired									(660		)
Other			1			5			5			(11		)
Balance, June 30, 2017	$	1,466	$	1,854		$	(2	)	$	(19,565	)	$	19,952		$	(3,947	)	$	330

XML

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2017

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

	Three Months Ended
	June 30, 2017					June 30, 2016
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	524	883.8	$	0.59	$	600	893.9	$	0.67
Stock options and restricted stock units			7.0					7.2
Diluted EPS	$	524	890.8	$	0.59	$	600	901.1	$	0.67

For the three months endedJune 30, 2017 and 2016, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 5,299,933 and 598,857, respectively.

	Six Months Ended
	June 30, 2017					June 30, 2016
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	1,094	884.2	$	1.24	$	1,133	893.8	$	1.27
Stock options and restricted stock units			6.7					6.9
Diluted EPS	$	1,094	890.9	$	1.23	$	1,133	900.7	$	1.26

For the six months endedJune 30, 2017 and 2016, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 9,051,702 and 356,541, respectively.

XML

Other Comprehensive Income (Loss) (Tables)

6 Months Ended

Jun. 30, 2017

Equity [Abstract]

Schedule of Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedJune 30, 2017 and 2016 were as follows:

	2017						2016
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	57		$	96		$	(8	)	$	(37	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	—			—			—			—
Amortization of net actuarial loss, transition and prior service costs (1)	19			12			16			12
Retirement plans and other retiree benefits adjustments	19			12			16			12
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	—			—			—			—
Reclassification of (gains) losses into net earnings on available-for-sale securities	—			—			—			—
Gains (losses) on available-for-sale securities	—			—			—			—
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(7		)	(4		)	7			6
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	1			1			2			1
Gains (losses) on cash flow hedges	(6		)	(3		)	9			7
Total Other comprehensive income (loss)	$	70		$	105		$	17		$	(18	)

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the six months endedJune 30, 2017 and 2016 were as follows:

	2017						2016
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	160		$	221		$	86		$	88
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	—			—			—			—
Amortization of net actuarial loss, transition and prior service costs (1)	37			25			32			23
Retirement plans and other retiree benefits adjustments	37			25			32			23
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	—			—			—			—
Reclassification of (gains) losses into net earnings on available-for-sale securities	—			—			—			—
Gains (losses) on available-for-sale securities	—			—			—			—
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	(20		)	(12		)	(7		)	(4		)
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(2		)	(1		)	—			—
Gains (losses) on cash flow hedges	(22		)	(13		)	(7		)	(4		)
Total Other comprehensive income (loss)	$	175		$	233		$	111		$	107

⁽¹⁾ These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 9, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾ These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

XML

Retirement Plans and Other Retiree Benefits (Tables)

6 Months Ended

Jun. 30, 2017

Compensation and Retirement Disclosure [Abstract]

Components Of Net Periodic Benefit Cost

Components of Net periodic benefit cost for the three and six months ended June 30, 2017 and 2016 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended June 30,
	2017			2016			2017			2016			2017		2016
Service cost	$	1		$	1		$	3		$	4		$	4	$	3
Interest cost	23			26			5			6			10		11
ESOP offset	—			—			—			—			—		(1		)
Expected return on plan assets	(28		)	(28		)	(5		)	(6		)	—		—
Amortization of transition and prior service costs (credits)	—			—			—			—			—		—
Amortization of actuarial loss (gain)	12			10			3			2			4		4
Net periodic benefit cost	$	8		$	9		$	6		$	6		$	18	$	17

	Pension Benefits												Other Retiree Benefits
	United States						International
	Six Months Ended June 30,
	2017			2016			2017			2016			2017		2016
Service cost	$	1		$	1		$	7		$	8		$	8	$	6
Interest cost	47			53			10			12			21		22
ESOP offset	—			—			—			—			—		(1		)
Expected return on plan assets	(55		)	(55		)	(10		)	(11		)	—		—
Amortization of transition and prior service costs (credits)	—			—			—			—			—		—
Amortization of actuarial loss (gain)	24			20			5			4			8		8
Net periodic benefit cost	$	17		$	19		$	12		$	13		$	37	$	35

XML

Segment Information (Tables)

6 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Net Sales and Operating Profit by Segment

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016
Net sales
Oral, Personal and Home Care
North America	$	764		$	793		$	1,524		$	1,593
Latin America	1,002			938			1,926			1,786
Europe	584			606			1,142			1,194
Asia Pacific	663			697			1,383			1,440
Africa/Eurasia	241			239			487			470
Total Oral, Personal and Home Care	3,254			3,273			6,462			6,483
Pet Nutrition	572			572			1,126			1,124
Total Net sales	$	3,826		$	3,845		$	7,588		$	7,607
Operating profit
Oral, Personal and Home Care
North America	$	241		$	250		$	474		$	489
Latin America	308			284			577			531
Europe	145			138			285			279
Asia Pacific	205			219			424			438
Africa/Eurasia	45			45			90			88
Total Oral, Personal and Home Care	944			936			1,850			1,825
Pet Nutrition	163			162			320			317
Corporate	(254		)	(154		)	(432		)	(331		)
Total Operating profit	$	853		$	944		$	1,738		$	1,811

XML

Fair Value Measurements and Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2017

Financial Instruments and Fair Value Measurements [Abstract]

Schedule of derivative instruments

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at June 30, 2017 and December 31, 2016:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		6/30/17		12/31/16			6/30/17		12/31/16
Interest rate swap contracts	Other current assets	$	—	$	1	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	—		1		Other liabilities	1		—
Foreign currency contracts	Other current assets	13		29		Other accruals	28		4
Foreign currency contracts	Other assets	—		5		Other liabilities	26		—
Commodity contracts	Other current assets	—		—		Other accruals	—		—
Total designated		$	13	$	36		$	55	$	4
Derivatives not designated
Foreign currency contracts	Other current assets	$	—	$	—	Other accruals	$	1	$	—
Total not designated		$	—	$	—		$	1	$	—
Total derivative instruments		$	13	$	36		$	56	$	4
Other financial instruments
Marketable securities	Other current assets	$	144	$	23
Total other financial instruments		$	144	$	23

Activity related to fair value hedges

Activity related to fair value hedges recorded during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017									2016
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at June 30,	$	930		$	600		$	1,530		$	347		$	1,250		$	1,597
Three months ended June 30,
Gain (loss) on derivatives	(3		)	—			(3		)	(6		)	1			(5		)
Gain (loss) on hedged items	3			—			3			6			(1		)	5
Six months ended June 30,
Gain (loss) on derivatives	(1		)	(2		)	(3		)	(5		)	9			4
Gain (loss) on hedged items	1			2			3			5			(9		)	(4		)

Activity related to cash flow hedges

Activity related to cash flow hedges recorded during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017								2016
	Foreign Currency Contracts			Commodity Contracts		Total			Foreign Currency Contracts			Commodity Contracts		Total
Notional Value at June 30,	$	719		$	2	$	721		$	705		$	9	$	714
Three months ended June 30,
Gain (loss) recognized in OCI	(7		)	—		(7		)	5			2		7
Gain (loss) reclassified into Cost of sales	(1		)	—		(1		)	(3		)	1		(2		)
Six months ended June 30,
Gain (loss) recognized in OCI	(20		)	—		(20		)	(9		)	2		(7		)
Gain (loss) reclassified into Cost of sales	2			—		2			—			—		—

Activity related to net investment hedges

Activity related to net investment hedges recorded during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017									2016
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at June 30,	$	800		$	572		$	1,372		$	895		$	1,280		$	2,175
Three months ended June 30,
Gain (loss) on instruments	(28		)	(78		)	(106		)	10			26			36
Gain (loss) on hedged items	27			78			105			(7		)	(26		)	(33		)
Six months ended June 30,
Gain (loss) on instruments	(46		)	(93		)	(139		)	(16		)	(23		)	(39		)
Gain (loss) on hedged items	47			93			140			16			23			39

Activity related to derivatives not designated as hedging instruments

Activity related to these contracts during the three and six months ended June 30, 2017 and 2016 was as follows:

	2017		2016
	Foreign Currency Contracts		Foreign Currency Contracts
Notional Value at June 30,	$	48	$	5
Three months ended June 30,
Gain (loss) on instruments	—		2
Gain (loss) on hedged items	—		(2		)
Six months ended June 30,
Gain (loss) on instruments	—		5
Gain (loss) on hedged items	—		(5		)

XML

Recent Accounting Pronouncements (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating profit	$ 853	$ 944	$ 1,738	$ 1,811
Net income attributable to Colgate-Palmolive Company	524	$ 600	1,094	$ 1,133
Excess tax benefits recognized	$ 8		$ 26
Scenario, Forecast | Accounting Standards Update 2017-07
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating profit					$ 100
Net income attributable to Colgate-Palmolive Company					$ 0

XML

Restructuring and Related Implementation Charges (Details) - 2012 Restructuring Program $ in Millions		6 Months Ended
	Oct. 29, 2015	Jun. 30, 2017 USD ($) position	Mar. 31, 2017 USD ($)
Restructuring Cost and Reserve [Line Items]
Duration of extension of the restructuring program	1 year
Expected percent of total charges resulting in cash expenditure		75.00%
Hill’s Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program		5.00%
Corporate
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program		40.00%
North America
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program		15.00%
Europe
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program		25.00%
Latin America
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program		5.00%
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program		5.00%
Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program		5.00%
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category		45.00%
Incremental Depreciation And Asset Impairment
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category		10.00%
Charges Resulting Directly From Exit Activities
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category		20.00%
Implementation Of New Strategies
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category		25.00%
Minimum | Expected Completion Date 2017
Restructuring Cost and Reserve [Line Items]
Restructuring program expected cost before tax		$ 1,500	$ 1,405
Restructuring program expected cost after tax		1,120	1,050
Restructuring program expected cost, upcoming fiscal year, before tax		275	180
Restructuring program expected cost, upcoming fiscal year, after tax		$ 210	140
Restructuring and related cost, expected number of positions eliminated (in positions) | position		3,300
Maximum | Expected Completion Date 2017
Restructuring Cost and Reserve [Line Items]
Restructuring program expected cost before tax		$ 1,585	1,585
Restructuring program expected cost after tax		1,170	1,170
Restructuring program expected cost, upcoming fiscal year, before tax		360	360
Restructuring program expected cost, upcoming fiscal year, after tax		$ 260	$ 260
Restructuring and related cost, expected number of positions eliminated (in positions) | position		3,800

XML

Restructuring and Related Implementation Charges (Details 1) - 2012 Restructuring Program - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Restructuring Cost and Reserve [Line Items]
Total 2012 Restructuring Program charges, pretax	$ 142	$ 59	$ 188	$ 114
Total 2012 Restructuring Program charges, aftertax	115	44	146	82
Cost of sales
Restructuring Cost and Reserve [Line Items]
Total 2012 Restructuring Program charges, pretax	21	12	35	20
Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Total 2012 Restructuring Program charges, pretax	17	14	38	40
Other (income) expense, net
Restructuring Cost and Reserve [Line Items]
Total 2012 Restructuring Program charges, pretax	$ 104	$ 33	$ 115	$ 54

XML

Restructuring and Related Implementation Charges (Details 2) - 2012 Restructuring Program	3 Months Ended		6 Months Ended		57 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017
Hill’s Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	2.00%	17.00%	4.00%	9.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					7.00%
Corporate
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	18.00%	17.00%	24.00%	24.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					39.00%
North America
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	17.00%	23.00%	22.00%	32.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					17.00%
Latin America
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	3.00%	6.00%	3.00%	7.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					4.00%
Europe
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	55.00%	6.00%	42.00%	7.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					24.00%
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	3.00%	9.00%	3.00%	6.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					3.00%
Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Percent of Total Restructuring Charges Related to Segment	2.00%	22.00%	2.00%	15.00%
Percent of Restructuring Charges Related to Segment, Program-to-date Accumulated Charges					6.00%

XML

Restructuring and Related Implementation Charges (Details 3) - 2012 Restructuring Program $ in Millions	Jun. 30, 2017 USD ($)
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 1,416
Aftertax charges related to the Restructuring Program to date	1,053
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	573
Incremental Depreciation
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	86
Asset Impairments
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	29
Other
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 728

XML

Restructuring and Related Implementation Charges (Details 4) - 2012 Restructuring Program - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 167		$ 181
Charges	142	$ 59	188	$ 114
Cash payments	(54)		(109)
Charges against assets	(5)		(10)
Foreign exchange	4		4
Ending Balance	254		254
Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning Balance	44		56
Charges	100		108
Cash payments	(8)		(27)
Charges against assets	(1)		(2)
Foreign exchange	3		3
Ending Balance	138		138
Incremental Depreciation
Restructuring Reserve [Roll Forward]
Beginning Balance	0		0
Charges	4		6
Cash payments	0		0
Charges against assets	(4)		(6)
Foreign exchange	0		0
Ending Balance	0		0
Asset Impairments
Restructuring Reserve [Roll Forward]
Beginning Balance	0		0
Charges	0		2
Cash payments	0		0
Charges against assets	0		(2)
Foreign exchange	0		0
Ending Balance	0		0
Other
Restructuring Reserve [Roll Forward]
Beginning Balance	123		125
Charges	38		72
Cash payments	(46)		(82)
Charges against assets	0		0
Foreign exchange	1		1
Ending Balance	116		116
Third party Incremental Cost
Restructuring Reserve [Roll Forward]
Charges	37		70
Contract Termination
Restructuring Reserve [Roll Forward]
Charges	$ 1		$ 2

XML

Inventories (Details) - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Raw materials and supplies	$ 241	$ 266
Work-in-process	47	42
Finished goods	911	863
Total Inventories	$ 1,199	$ 1,171

XML

Shareholders' Equity (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			$ 17
Net income	$ 560	$ 638	1,171	$ 1,212
Other comprehensive income (loss), net of tax	107	(24)	242	102
Ending balance	88		88
Accumulated other comprehensive income (loss), cumulative translation losses	2,991		2,991		$ 3,212
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefits costs	952		952		$ 977
Common Stock
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			1,466
Ending balance	1,466		1,466
Additional Paid-in Capital
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			1,691
Stock-based compensation expense			53
Shares issued for stock options			126
Shares issued for restricted stock units			(17)
Other			1
Ending balance	1,854		1,854
Unearned Compensation
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			(7)
Other			5
Ending balance	(2)		(2)
Treasury Stock
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			(19,135)
Shares issued for stock options			208
Shares issued for restricted stock units			17
Treasury stock acquired			(660)
Other			5
Ending balance	(19,565)		(19,565)
Retained Earnings
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			19,922
Net income			1,094
Dividends			(1,053)
Other			(11)
Ending balance	19,952		19,952
Accumulated Other Comprehensive Income (Loss)
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			(4,180)
Other comprehensive income (loss), net of tax	105	$ (18)	233	$ 107
Ending balance	(3,947)		(3,947)
Noncontrolling Interests
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			260
Net income			77
Other comprehensive income (loss), net of tax			9
Dividends			(16)
Ending balance	$ 330		$ 330

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Net income attributable to Colgate-Palmolive Company
Basic EPS	$ 524	$ 600	$ 1,094	$ 1,133
Diluted EPS	$ 524	$ 600	$ 1,094	$ 1,133
Shares
Basic EPS (in shares)	883,800,000	893,900,000	884,200,000	893,800,000
Stock options and restricted stock units (in shares)	7,000,000	7,200,000	6,700,000	6,900,000
Diluted EPS (in shares)	890,800,000	901,100,000	890,900,000	900,700,000
Per Share
Basic EPS (in dollars per share)	$ 0.59	$ 0.67	$ 1.24	$ 1.27
Diluted EPS (in dollars per share)	$ 0.59	$ 0.67	$ 1.23	$ 1.26
Antidilutive securities excluded from computation of earnings per share (in shares)	5,299,933	598,857	9,051,702	356,541

XML

Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total Other comprehensive income (loss), net of tax	$ 107	$ (24)	$ 242	$ 102
Cumulative translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), Pretax	57	(8)	160	86
Total Other comprehensive income (loss), net of tax	96	(37)	221	88
Retirement plans and other retiree benefits adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, Pretax	0	0	0	0
Reclassification from AOCI, Pretax	19	16	37	32
Other comprehensive income (loss), Pretax	19	16	37	32
Other comprehensive income (loss), before reclassifications, Net of Tax	0	0	0	0
Reclassification from AOCI, Net of Tax	12	12	25	23
Total Other comprehensive income (loss), net of tax	12	12	25	23
Available-for-sale securities:
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, Pretax	0	0	0	0
Reclassification from AOCI, Pretax	0	0	0	0
Other comprehensive income (loss), Pretax	0	0	0	0
Other comprehensive income (loss), before reclassifications, Net of Tax	0	0	0	0
Reclassification from AOCI, Net of Tax	0	0	0	0
Total Other comprehensive income (loss), net of tax	0	0	0	0
Cash flow hedges:
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), before reclassifications, Pretax	(7)	7	(20)	(7)
Reclassification from AOCI, Pretax	1	2	(2)	0
Other comprehensive income (loss), Pretax	(6)	9	(22)	(7)
Other comprehensive income (loss), before reclassifications, Net of Tax	(4)	6	(12)	(4)
Reclassification from AOCI, Net of Tax	1	1	(1)	0
Total Other comprehensive income (loss), net of tax	(3)	7	(13)	(4)
Total Other comprehensive income (loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss), Pretax	70	17	175	111
Total Other comprehensive income (loss), net of tax	$ 105	$ (18)	$ 233	$ 107

XML

Retirement Plans and Other Retiree Benefits (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Pension Benefits, United States
Components of net periodic benefit cost
Service cost	$ 1	$ 1	$ 1	$ 1
Interest cost	23	26	47	53
ESOP offset	0	0	0	0
Expected return on plan assets	(28)	(28)	(55)	(55)
Amortization of transition and prior service costs (credits)	0	0	0	0
Amortization of actuarial loss (gain)	12	10	24	20
Net periodic benefit cost	8	9	17	19
Voluntary benefit plan contribution			57	50
Pension Benefits, International
Components of net periodic benefit cost
Service cost	3	4	7	8
Interest cost	5	6	10	12
ESOP offset	0	0	0	0
Expected return on plan assets	(5)	(6)	(10)	(11)
Amortization of transition and prior service costs (credits)	0	0	0	0
Amortization of actuarial loss (gain)	3	2	5	4
Net periodic benefit cost	6	6	12	13
Other Retiree Benefits
Components of net periodic benefit cost
Service cost	4	3	8	6
Interest cost	10	11	21	22
ESOP offset	0	(1)	0	(1)
Expected return on plan assets	0	0	0	0
Amortization of transition and prior service costs (credits)	0	0	0	0
Amortization of actuarial loss (gain)	4	4	8	8
Net periodic benefit cost	$ 18	$ 17	$ 37	$ 35

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017
Income Tax Disclosure [Abstract]
Excess tax benefits recognized	$ 8		$ 26
Tax benefit from foreign Supreme Court decision		$ 13
Tax benefit from prior year tax positions currently being challenged	$ 15		$ 15

XML

Contingencies (Details) $ in Millions	1 Months Ended		3 Months Ended	6 Months Ended
	Sep. 30, 2015 appeal	Dec. 31, 2014 USD ($) company	Jun. 30, 2017 USD ($) case	Jun. 30, 2017 USD ($) case country_and_territory	Jul. 21, 2017 USD ($)	Mar. 31, 2017 case	Dec. 31, 2016 case
Loss Contingencies [Line Items]
Minimum number of countries and territories serving consumers (more than) (in countries and territories) | country_and_territory				200
Brazilian internal revenue authority, matter 1			$ 162	$ 162
Loss contingency, number of appeals lost (in appeals) | appeal	1
Brazilian internal revenue authority, matter 2			$ 71	$ 71
Number of consumer goods companies | company		13
Fine imposed french competition authority		$ 57
Fine imposed french competition authority - as a result of Sanex acquisition		$ 25
Loss contingency, pending claims, number (in cases) | case			174	174		146	115
Loss contingency, new claims filed, number (in cases) | case			36	77
Loss contingency, claims dismissed or settled, number (in cases) | case			8	18
Minimum
Loss Contingencies [Line Items]
Range of reasonably possible losses			$ 0	$ 0
Maximum
Loss Contingencies [Line Items]
Range of reasonably possible losses			$ 225	$ 225
Subsequent Event
Loss Contingencies [Line Items]
Fine imposed by greek competition authority					$ 11

XML

Segment Information (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($) segment	Jun. 30, 2016 USD ($)
Segment Reporting [Abstract]
Number of product segments (in segments) | segment			2
Number of operating segments (in segments) | segment			5
Number of reportable segments (in segments) | segment			5
Segment Reporting Information [Line Items]
Total Net sales	$ 3,826	$ 3,845	$ 7,588	$ 7,607
Total Operating profit	853	944	1,738	1,811
2012 Restructuring Program
Segment Reporting Information [Line Items]
Total 2012 Restructuring Program charges, pretax	$ 142	59	$ 188	114
Sales Revenue, Net
Segment Reporting Information [Line Items]
Percentage of consolidated Net sales represented by sales outside US	75.00%		75.00%
Percentage of consolidated Net sales coming from emerging markets	50.00%		50.00%
Operating Segments | Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Total Net sales	$ 3,254	3,273	$ 6,462	6,483
Total Operating profit	944	936	1,850	1,825
Operating Segments | Oral, Personal and Home Care | North America
Segment Reporting Information [Line Items]
Total Net sales	764	793	1,524	1,593
Total Operating profit	241	250	474	489
Operating Segments | Oral, Personal and Home Care | Latin America
Segment Reporting Information [Line Items]
Total Net sales	1,002	938	1,926	1,786
Total Operating profit	308	284	577	531
Operating Segments | Oral, Personal and Home Care | Europe
Segment Reporting Information [Line Items]
Total Net sales	584	606	1,142	1,194
Total Operating profit	145	138	285	279
Operating Segments | Oral, Personal and Home Care | Asia Pacific
Segment Reporting Information [Line Items]
Total Net sales	663	697	1,383	1,440
Total Operating profit	205	219	424	438
Operating Segments | Oral, Personal and Home Care | Africa/Eurasia
Segment Reporting Information [Line Items]
Total Net sales	241	239	487	470
Total Operating profit	45	45	90	88
Operating Segments | Pet Nutrition
Segment Reporting Information [Line Items]
Total Net sales	572	572	1,126	1,124
Total Operating profit	163	162	320	317
Corporate
Segment Reporting Information [Line Items]
Total Operating profit	$ (254)	$ (154)	$ (432)	$ (331)

XML

Fair Value Measurements and Financial Instruments (Details 1) - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Designated derivative instruments
Derivative assets, designated	$ 13	$ 36
Derivative liabilities, designated	55	4
Derivatives not designated
Derivative assets not designated	0	0
Derivative liabilities not designated	1	0
Total derivative instruments, Assets	13	36
Total derivative instruments, Liabilities	56	4
Other financial instruments
Total other financial instruments	144	23
Other current assets
Other financial instruments
Marketable securities	144	23
Other current assets | Interest rate swap contracts
Designated derivative instruments
Derivative assets, designated	0	1
Other current assets | Foreign currency contracts
Designated derivative instruments
Derivative assets, designated	13	29
Derivatives not designated
Derivative assets not designated	0	0
Other current assets | Commodity contracts
Designated derivative instruments
Derivative assets, designated	0	0
Other assets | Interest rate swap contracts
Designated derivative instruments
Derivative assets, designated	0	1
Other assets | Foreign currency contracts
Designated derivative instruments
Derivative assets, designated	0	5
Other accruals | Interest rate swap contracts
Designated derivative instruments
Derivative liabilities, designated	0	0
Other accruals | Foreign currency contracts
Designated derivative instruments
Derivative liabilities, designated	28	4
Derivatives not designated
Derivative liabilities not designated	1	0
Other accruals | Commodity contracts
Designated derivative instruments
Derivative liabilities, designated	0	0
Other liabilities | Interest rate swap contracts
Designated derivative instruments
Derivative liabilities, designated	1	0
Other liabilities | Foreign currency contracts
Designated derivative instruments
Derivative liabilities, designated	$ 26	$ 0

XML

Fair Value Measurements and Financial Instruments (Details 2) - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Carrying Value
Debt Instrument [Line Items]
Carrying value of long-term debt	$ 6,506	$ 6,520
Fair Value, Inputs, Level 2
Debt Instrument [Line Items]
Estimated fair value of long-term debt	$ 6,710	$ 6,717

XML

Fair Value Measurements and Financial Instruments (Details 3) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Foreign Currency Contracts | Derivatives Not Designated as Hedging Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	$ 48	$ 5	$ 48	$ 5
Activity related to derivatives not designated as hedging instruments [Abstract]
Gain (loss) on instruments	0	2	0	5
Gain (loss) on hedged items	0	(2)	0	(5)
Fair Value Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	1,530	1,597	1,530	1,597
Activity related to fair value hedges [Abstract]
Gain (loss) on derivatives	(3)	(5)	(3)	4
Gain (loss) on hedged items	3	5	3	(4)
Fair Value Hedges | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	930	347	930	347
Activity related to fair value hedges [Abstract]
Gain (loss) on derivatives	(3)	(6)	(1)	(5)
Gain (loss) on hedged items	3	6	1	5
Fair Value Hedges | Interest Rate Swaps
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	600	1,250	600	1,250
Activity related to fair value hedges [Abstract]
Gain (loss) on derivatives	0	1	(2)	9
Gain (loss) on hedged items	0	(1)	2	(9)
Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	721	714	721	714
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	(7)	7	(20)	(7)
Gain (loss) reclassified into Cost of sales	(1)	(2)	2	0
Cash Flow Hedges | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	719	705	719	705
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	(7)	5	(20)	(9)
Gain (loss) reclassified into Cost of sales	(1)	(3)	2	0
Cash Flow Hedges | Commodity Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	2	9	2	9
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	0	2	0	2
Gain (loss) reclassified into Cost of sales	0	1	0	0
Net Investment Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	1,372	2,175	1,372	2,175
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	(106)	36	(139)	(39)
Gain (loss) on hedged items	105	(33)	140	39
Net Investment Hedges | Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	800	895	800	895
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	(28)	10	(46)	(16)
Gain (loss) on hedged items	27	(7)	47	16
Net Investment Hedges | Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional value	572	1,280	572	1,280
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	(78)	26	(93)	(23)
Gain (loss) on hedged items	$ 78	$ (26)	$ 93	$ 23

XML

Fair Value Measurements and Financial Instruments (Details 4) - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Other current assets
Schedule of Available-for-sale Securities [Line Items]
Marketable securities	$ 144	$ 23
Other current assets | Bonds Issued By Argentinian Government
Schedule of Available-for-sale Securities [Line Items]
Marketable securities	11
Assets
Schedule of Available-for-sale Securities [Line Items]
Held-to-maturity securities	11
Fair Value, Inputs, Level 1 | Other current assets | Deposits
Schedule of Available-for-sale Securities [Line Items]
Marketable securities	144
Fair Value, Inputs, Level 2 | Assets
Schedule of Available-for-sale Securities [Line Items]
Held-to-maturity securities, fair value	$ 11